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SUMMARY
Adipose tissue is an important site for lipid storage, energy homeostasis, and whole-body
insulin sensitivity. It is important to understand the mechanisms involved in adipose tissue
development and function, which can be regulated by the endocrine actions of various pep-
tide and steroid hormones. Recent studies have revealed that white and brown adipocytes can
be derived from distinct precursor cells. This review will focus on transcriptional control of
adipogenesis and its regulation by several endocrine hormones. The general functions and
cellular origins of adipose tissue and how the modulation of adipocyte development pertains
to metabolic disease states will also be considered.
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1 INTRODUCTION
1.1 Adipose Tissue: A Dynamic Organ
Studies over the last two decades have established adipose
tissue as a dynamic organ that carries out several important
physiological processes. There are two distinct classifica-
tions of adipose tissue: white adipose tissue (WAT) and
brown adipose tissue (BAT). WAT accounts for the major-
ity of fat present in adult humans and is a critical site for
energy homeostasis, insulin signaling, and endocrine ac-
tion. BAT is predominantly responsible for nonshivering
thermogenesis, which is mediated by uncoupling protein-1
(UCP1) in the mitochondria (Farmer 2008). Brown fat
has been well established as an important fat depot in post-
natal babies and in a variety of mammals. To great surprise
within the scientific community, several recent studies us-
ing 18F-fluorodeoxyglucose positron emission tomography
and computed tomography suggest that BAT depots are
also present in the thoracic and supraclavicular regions of
adult humans (Nedergaard et al. 2007; Cypess et al. 2009).
Additional studies suggest that this adipose tissue may be
metabolically active BAT because of the presence of UCP1,
an important protein used to classify BAT (Zingaretti et al.
2009). Recent studies revealed surprising evidence suggest-
ing that brown adipocytes are detectable in subcutaneous
WAT in mice (Barbatelli et al. 2010). These observations
have increased interest in the potential use of brown adi-
pocytes in correcting WAT pathologies.
Adipose tissue comprises a variety of cell types, includ-
ing endothelial cells, blood cells, fibroblasts, pericytes, pre-
adipocytes, macrophages, and other immune cells (Geloen
et al. 1989). However, the predominant cells present in
adipose tissue are mature adipocytes. Brown and white
adipocytes require key transcription factors that are neces-
sary to promote preadipocyte differentiation into mature
adipocytes. As shown in Figure 1, these transcriptional
regulators include critical factors like peroxisome prolifer-
ator-activated receptor g (PPARg) and other transcription
factor families, including CCAAT/enhancer-binding pro-
teins (C/EBPs), signal transducers and activators of tran-
scription (STATs), and Kruppel-like factor (KLF) proteins.
The specific roles of these transcription factors will be dis-
cussed in a section on positive regulators of adipogenesis.
1.2 The Cellular Origins of Adipocytes
Our understanding of the origins of adipocytes has changed
substantially in the last five years. In the recent past it was
largely accepted that both brown and white adipocytes arose
from resident mesenchymal progenitor cells that were pre-
sent in adipose tissue. This idea was supported by evidence
indicating that both brown and white adipocytes require
PPARg for development. However, the notion that brown
and white cells arise from a similar origin is outdated. For
example, it has been shown that brown adipocytes present





















Clonal expansion Increasing lipid accumulation and insulin sensitivity
Figure 1. Transcription factors that are positive and negative effectors of adipocyte development. Many transcription
factors are induced during adipocyte differentiation. Some of these, like members of the AP-1 family, are induced
during clonal expansion. Other transcription factors, like PPARg, promote adipocyte differentiation. Adipocyte
development is also influenced by several transcription factor families that have negative effects on adipogenesis.
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precursor cells (Seale et al. 2008). The transcriptional reg-
ulator PRDM16 has been shown to control the develop-
ment of brown adipocytes in classic BAT depots (Seale et al.
2007, 2008; Kajimura et al. 2008). However, brown fat–like
adipocytes are found interspersed in WAT in both humans
and rodents. As shown in Figure 2, the development of these
cells is enhanced by b3-adrenergic stimulation, chronic
activation of PPARg, or adaptation to cold response (Hut-
tunen et al. 1981; Cousin et al. 1992; Ghorbani and Himms-
Hagen 1997; Guerra et al. 1998; Himms-Hagen et al.
2000; Xue et al. 2005; Petrovic et al. 2010). These brown
fat-like cells present in WAT depots have been referred to as
brite cells (brown in white), beige cells, adaptive brown fat
cells, and recruitable brown fat cells (Enerback 2009; Ishi-
bashi and Seale 2010; Petrovic et al. 2010). It was originally
reported that PRDM16 was present only in BAT, but not
WAT (Seale et al. 2007). However, this study only examined
the epididymal WAT depot. It is now known that PRDM16
is highly expressed in subcutaneous WAT, and transgenic
expression of PRDM16 in all adipose tissues results in a
transformation of subcutaneous WAT to a brown fat–like
phenotype (Seale et al. 2011). As reviewed in Figure 2, these
results suggest that brown cells in BAT and brown fat-like
cells in WAT have different cellular origins, and the tran-
scriptional modulator PRDM16 plays an important role in
both of these cell types to regulate genes required for ther-
mogenesis (Seale et al. 2011). To make the situation more
complex, there is also evidence to indicate that bone mar-
row progenitor–derived adipocytes and adipocyte progen-
itors can arise from hematopoietic cells via the myeloid
lineage (Majka et al. 2010). Collectively, these recent studies
suggest that our understanding of the origin of adipocytes
is rapidly changing, and additional studies will be neces-
sary to clarify our understanding of this emerging area of
biology.
2 WAT VERSUS BAT
2.1 Adipocyte Morphology
The morphological differences between brown and white
adipocytes can be readily observed via light or electron
microscope. White adipocytes are generally spherical cells
with an average diameter in a young animal of less than
10 mm. However, this size can increase to as much as
100 mm, particularly in the epididymal fat depots (Cinti
2005). The organelles of white adipocytes are typically sub-
jected to a confined arrangement because of the presence of
a unilocular lipid droplet that occupies the majority of the
cytosol. The nucleus is usually compressed between the fat
and plasma membrane. There is a sparse distribution of
mitochondria in white adipocytes and other cellular organ-
elles, such as the Golgi and smooth and rough endoplasmic
reticulum.
Brown adipose tissue is innervated by the sympathetic
nervous system and is well vascularized. Brown adipocytes
are typically ellipsoid in shape and range from 15–50 mm
in size and contain multilocular lipid droplets (Cinti 2005).
The nucleus of these cells is relatively centralized within the
Mesenchymal
precursor












Figure 2. White and brown adipocytes are derived from distinct precursor cells and have distinct morphological
characteristics. White adipocytes can be derived from mesenchymal precursor cells. Brown adipocytes are derived
from Myf5-expressing precursor cells. Mature brown adipocytes contain multilocular lipid droplets and are mito-
chondria rich. PRDM16 is present in both brown and white adipocytes and is an important factor in transforming
white adipocytes to beige adipocytes.
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cytoplasm and all other classical organelles are present. The
hallmark components of brown adipocytes are their abun-
dant distribution of cristae-rich mitochondria and the large-
ly exclusive expression of the proton transporter UCP1
(Cannon et al. 1982). When UCP1 is ectopically expressed
in subcutaneous WAT, the population of cells characteristic
of brown adipocytes is increased (Rossmeisl et al. 2002).
Recent studies have indicated that UCP1 can be present in
WAT (Barbatelli et al. 2010), but as previously indicated,
this is likely caused by the presence of brown fat-like adi-
pocytes in WAT.
2.2 Adipocyte Physiology
The first study to show that adipose tissue is a bona fide
endocrine organ was that which characterized the satiety
hormone leptin (Zhang et al. 1994). Adiponectin is another
adipocyte-specific hormone (Scherer et al. 1995; Hu et al.
1996; Maeda et al. 1996) that regulates several physiological
processes. The most clearly understood are its effects on
glucose and lipid metabolism (Berg et al. 2001; Yamauchi
et al. 2002). Adiponectin has also been shown to be cardio-
protective in mice and humans (Chen et al. 2003; Shibata
et al. 2004), and more recent studies indicate it can act on
the brain to regulate satiety (Kubota et al. 2007). Another
adipocyte-specific hormone was identified as a member of
the “found in inflammatory zone” (FIZZ) family (Hol-
comb et al. 2000). Immunoneutralization studies suggested
that this hormone, resistin, might be involved in the path-
ogenesis of insulin resistance (Steppan et al. 2001). In these
studies insulin sensitivity was improved when antiresistin
IgG was administered to rodents with obesity/type 2 dia-
betes mellitus. It is important to note that the distribution
pattern of resistin in humans is different from that in mice.
Resistin is expressed at low levels in human adipocytes
(Nagaev and Smith 2001; Savage et al. 2001; Janke et al.
2002), but the majority of resistin expressed in humans is
found in monocytes and macrophages that reside in adi-
pose tissue (Savage et al. 2001; Patel et al. 2003). A highly
innovative experiment sought to determine if the resistin
derived from human macrophages was sufficient to confer
insulin resistance. Researchers engineered a mouse model
that was deficient in adipocyte-derived resistin and pro-
duced human resistin from a macrophage-specific promot-
er. These mice are referred to as humanized resistin mice
and exhibit a phenotype of insulin resistance and WAT
inflammation (Qatanani et al. 2009). These studies indicate
that resistin has similar functions in mice and humans
despite the differences in expression.
WAT is a key organ that carries out insulin-stimulated
glucose uptake, an important physiological process that is
mediated by a signal pathway in which insulin activates
a cascade that results in glucose transporter-4 (GLUT4)
translocation to the plasma membrane to facilitate an in-
crease in the influx of glucose. The details of this mecha-
nism have been well studied worldwide by numerous
groups. Brown adipocytes do not take up significant
amounts of glucose on insulin stimulation. However, they
are responsive to the sympathetic nervous system, and nor-
epinephrine can stimulate the uptake of glucose indepen-
dent of insulin (Shimizu et al. 1996).
Brown and white adipocytes store and metabolize lipids
in different manners. White adipocytes accumulate nutri-
ent-derived triglycerides and release them by lipolysis dur-
ing periods of fasting, whereas brown adipocytes oxidize
their lipid stores in an elegant heat-producing pathway in
which the primary player is UCP1. UCP1 is highly ex-
pressed in brown adipocytes and is the central mediator
in the ability of BAT to produce adaptive heat. The impor-
tance of UCP1 was shown in knockout mice, whereby
UCP1-deficient mice were unable to survive long-term ex-
posure to cold (Golozoubova et al. 2001). UCP1 is localized
at the mitochondrial inner membrane, where it reduces the
proton gradient across the membrane by facilitating the
flow of protons from the intermembrane space of the mi-
tochondria back into the matrix, thus releasing heat rather
than producing ATP. Subthermoneutral temperatures trig-
ger this pathway and stimulate the sympathetic nervous
system to release norepinephrine. Norepinephrine acts via
b-adrenergic receptors to play a role in the activation of
thermogenesis. The physiological importance of the b-ad-
renergic receptors was shown in mice deficient of all three
b-adrenergic receptors. These mice had reduced metabolic
rates and susceptibility to severe obesity upon high-fat
feeding (Bachman et al. 2002).
2.3 Model Systems of Adipogenesis
A variety of cellular model systems are used to study the
molecular pathways of adipogenesis and adipocyte func-
tion in vitro. These models can largely be placed in two
classes. The first group includes pluripotent fibroblasts that
have the ability to differentiate into several cell types, in-
cluding myocytes, chondrocytes, and adipocytes. This class
includes the 10T1/2, BALB/c-3T3, RCJ3.1, and CHEF/18
fibroblast cell lines. The second group of model systems
comprises fibroblastlike preadipocytes that are committed
to differentiating into adipocytes and includes 3T3-L1,
3T3-F422A, 1246, Ob1771, TA1, and 30A5 preadipocytes.
This latter class represents the cells used most frequently to
study adipogenesis.
10T1/2 fibroblasts, established in 1973 from 14- to
17-day-old C3H mouse embryos (Reznikoff et al. 1973),
can generate committed preadipocytes, premyocytes, or
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prechondrocytes when treated with 5-azacytidine, an in-
hibitor of DNA methylation (Taylor and Jones 1979). Bone
morphogenetic protein-4 (BMP4) is capable of inducing
10T1/2 cells to convert into committed preadipocytes that
can develop into mature fat cells when provided with dif-
ferentiation media (Tang et al. 2004). Ectopic expression of
important proadipogenic transcription factors, including
PPARg (Brun et al. 1996), members of the C/EBP family
(Freytag et al. 1994; Yeh et al. 1995; Wu et al. 1996), and
STAT5 (Floyd and Stephens 2003), can also confer adipo-
cyte differentiation in these cells.
3T3-F442A and 3T3-L1 are the two most extensively
characterized and used preadipocyte cell lines. Both of
these lines were derived from disaggregated 17- to 19-
day-old Swiss 3T3 mouse embryos (Green and Meuth
1974; Green and Kehinde 1976). However, unlike 3T3-L1
cells, 3T3-F442A preadipocytes do not require glucocorti-
coid-supplemented differentiation cocktail to induce adi-
pogenesis (Rubin et al. 1978; Spiegelman and Ginty 1983;
Moustaid et al. 1990). It is commonly believed that 3T3-
F442A precursors are at a more advanced stage of commit-
ment than 3T3-L1’s. Implantation of 3T3-F44A, but not
3T3-L1, preadipocytes into athymic mice results in the
generation of ectopic fat that is histologically (Green and
Kehinde 1979) and biochemically (Mandrup et al. 1997)
indistinguishable from adipose tissue. The 3T3-F442A and
3T3-L1 cell lines are preferred because they develop a
homogeneous population of mature adipocytes that are
morphologically (Novikoff et al. 1980) and biochemically
(MacDougald and Lane 1995) similar to adipocytes in situ.
2.4 Positive Effectors of Adipogenesis
The development of fully differentiated mature adipocytes
from precursor cells is an elegant progression of the se-
quential activation of a battery of transcription factors.
In white adipocytes this sequence commences with the
activation of members of the activating protein-1 (AP-1)
family of transcription factors, and continues with the in-
duction and expression of PPARg, a critical proadipogenic
transcription factor (see Fig. 1). Other transcription factors
facilitate adipocyte maturation, including STATs, members
of the KLF family of proteins, sterol response element–
binding protein-1 (SREBP-1), and members of the C/EBP
family. There are also potent negative repressors of adipo-
cyte differentiation, including preadipocyte factor-1 (Pref-
1) and members of the GATA and Wnt families.
2.4.1 AP-1
AP-1 is a large group of transcription factors that include
v-Jun, c-Jun, JunB, JunD, v-Fos, c-Fos, FosB, Fra1, Fra2, and
activating transcription factors (ATF2, ATF3/LRF1, and
B-ATF). On activation the AP-1 proteins form homodimers
or heterodimers and interact with DNA to regulate genes
involved in differentiation and proliferation of various cell
types. In addition, AP-1 can be a part of cellular proapop-
totic machinery (Colotta et al. 1992; Johnson et al. 1996).
In regards to adipocyte development, in vitro studies per-
formed with 3T3-L1 and 3T3-F442A preadipocytes have
found the induction of mRNA expression of c-Fos, c-Jun,
Fos-B, and Fra1 at the onset of adipocyte differentiation.
AP-1 modulates the expression of aP2, particularly via in-
teraction between c-Fos and the FSE2 regulatory sequence
of the aP2 promoter (Distel et al. 1987). Additionally, mice
that have fat-specific expression of A-ZIP/F, a dominant-
negative protein that hinders bZIP–DNA interaction and
disrupts C/EBP and Jun transcriptional activity, show im-
paired WAT development and have significantly less BAT
(Moitra et al. 1998).
2.4.2 KLFs
This family of transcription factors has strong homology,
particularly at the zinc finger–DNA interaction domains,
with the Drosophila embryonic pattern regulator protein
Kruppel (Schuh et al. 1986). To date there are 17 members
of the C2H2 zinc finger Kruppel-like family of transcrip-
tion factors, and they are implicated in development, cel-
lular differentiation, and proliferation (reviewed in Dang
et al. 2000). Members of this family can assume opposing
transcriptional roles, some being activators of gene tran-
scription while others act as repressors of transcription.
KLFs 4, 5, 6, and 15 have been shown to be positive effectors
of adipogenesis.
KLF5 expression is induced during the early stages of
adipocyte differentiation and has been shown to be neces-
sary for adipocyte differentiation in vitro and in vivo (Oishi
et al. 2005). KLF5 small interfering RNA (siRNA) expres-
sion in 3T3-L1 preadipocytes results in impaired adipocyte
differentiation and a substantial decrease in lipid accumu-
lation. Also, KLF5+/2 heterozygote mice have a reduction
in fat pad size (Oishi et al. 2005). KLF15 is also essential for
adipogenesis (Mori et al. 2005). KLF15 is highly induced
during the differentiation of 3T3-L1 cells, and dominant-
negative mutations and RNA interference knockdowns
result in attenuated adipocyte differentiation (Mori et al.
2005). These studies also showed that ectopic expression of
KLF15 can confer adipogenesis by inducing activation of
PPARg in NIH-3T3 cells. KLF15 plays another key role in
adipocyte physiology, as studies have shown an interaction
of KLF15 with the GLUT4 promoter, indicating a link be-
tween adipocyte insulin sensitivity and KLF15 (Gray et al.
2002). KLF4 is also highly expressed in white adipose tissue,
but it is expressed at much lower levels in vitro in mature
Adipogenesis
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3T3-L1 adipocytes. Further analysis revealed that the en-
richment of KLF4 in adipose tissue can be attributed to its
high expression in preadipocytes of the stromal vascular
fraction of WAT (Soukas et al. 2001). These findings led to
the hypothesis that KLF4 may also be a key regulator of
adipogenesis. KLF4 mRNA is induced early in 3T3-L1 dif-
ferentiation, and siRNA knockdown results in marked de-
creases in lipid accumulation (Birsoy et al. 2008). KLF6 has
also been identified as a positive effector of adipogenesis.
KLF6 is induced during 3T3-L1 adipogenesis (Inuzuka
et al. 1999), and studies suggest that KLF6 promotes adi-
pocyte differentiation by repressing delta-like protein-1
(DLK-1) gene expression in 3T3-L1 preadipocytes (Li et al.
2005). Taken together, these studies show that KLF4, KLF5,
KLF6, and KLF15 are transcription factors that promote
adipocyte development.
2.4.3 C/EBPs
C/EBPs comprise another family of basic leucine zipper
transcription factors. There are six C/EBP isoforms, all of
which possess a highly conserved bZIP domain that serves
as a point of interaction for homodimerization or hetero-
dimerization with other family members (Vinson et al.
1989). The most common nomenclature for the members
is C/EBPs a, b, d, g, 1, and z. In vivo and in vitro exper-
iments have shown that C/EBPs a, b, and d promote ad-
ipocyte differentiation. McKnight and colleagues presented
the first set of data to show the orchestrated induction of
these family members during adipogenesis. C/EBPb is pri-
marily induced by methylisobutylxanthine, and C/EBPd is
highly induced by dexamethasone in the very early stages of
adipogenesis. C/EBPb and C/EBPd work in concert to
trans-activate C/EBPa (Cao et al. 1991). Loss-of-function
experiments in 3T3-L1 and NIH-3T3 cell lines confirmed
the importance of C/EBPb and -d, as inhibition of either
of these C/EBPs resulted in the attenuation of adipogenesis
(Yeh et al. 1995). Interestingly, ectopic expression studies
with C/EBPa showed that it was sufficient to induce adipo-
genesis in precursor cell lines that are susceptible to adipo-
genesis, but also in nonprecursor fibroblasts (Freytag et al.
1994; Yeh et al. 1995). In vivo studies indicate that C/EBPb-
and/or -d-deficient mice show defective adipose tissue de-
velopment (Tanaka et al. 1997). C/EBPa-deficientmice have
a phenotype of substantially low lipid accumulation (Wang
et al. 1995; Flodby et al. 1996).
2.4.4 SREBP-1
This basic helix-loop-helix regulatory molecule was origi-
nally termed ADD-1, the adipocyte determination and dif-
ferentiation factor-1 (Tontonoz et al. 1993). ADD-1 was
identified in a rat adipocyte cDNA expression library screen
as a factor that binds to an E-box domain, a DNA recog-
nition site for basic helix-loop-helix proteins. Northern
blot analysis showed a substantial increase in ADD-1
mRNA expression during adipocyte differentiation in three
well-established models of adipocyte development: 3T3-
F442A, 3T3-L1, and 10T1/2 cells. The human homolog
of the same protein can bind the sterol response element
in the promoter region of the low-density lipoprotein re-
ceptor, thus labeling it sterol response element–binding
protein-1 (SREBP-1) (Yokoyama et al. 1993). To date there
are three isoforms of SREBP: SREBP-1a, SREBP-1c, and
SREBP-2. SREBP-1a and SREBP-1c originate from the same
gene through utilization of different promoters (Hua et al.
1995). SREBP-1a is the more potent transcription factor
because of a longer NH3-terminal DNA-binding domain
(Shimano et al. 1997a). SREBP-1c is the predominantly
expressed isoform in white adipose tissue (Shimomura
et al. 1997) and a chief regulator of lipogenic gene tran-
scription. SREBP-2 is transcribed from an alternate gene
and primarily regulates the expression of genes involved in
cholesterol biosynthesis (Horton et al. 1998).
In vitro evidence suggested that ADD-1/SREBP-1 is a
critical factor in adipocyte development. Ectopic expres-
sion of ADD-1/SREBP-1 in NIH-3T3 fibroblasts in the
presence of hormonal induction cocktail resulted in differ-
entiation that was accompanied by increased expression of
adipocyte-specific genes and lipid accumulation (Kim and
Spiegelman 1996). Ectopic expression of a dominant-neg-
ative ADD-1 that contained a point mutation within the
DNA-binding domain caused profound inhibition of dif-
ferentiation and repression of adipocyte marker genes (87).
In vivo studies exploring the involvement of SREBP-1 in
adipogenesis are less persuasive. Transgenic mice with adi-
pose tissue–specific knockout of SREBP-1 had minimal in-
hibition of adipose tissue development, with no overt effects
on the expression of adipocyte marker genes (Shimano et al.
1997b). Ectopic expression of a constitutively active SREBP-
1c surprisingly conferred lipodystrophy in mice (Shimomu-
ra et al. 1998). Other in vivo studies with a double-mutant
leptin-deficient ob/ob mice and SREBP-12/2 mice suggest-
ed that SREBP-1 was not needed for adipose tissue expan-
sion (Yahagi et al. 2002). Overall, the data suggest that
although there is in vitro evidence to show SREBP-1 is re-
quired for adipocyte differentiation, the in vivo studies con-
sistently show that SREBP-1 expression is not critical for
adipose tissue development and/or expansion.
2.4.5 STATs
There are seven STAT proteins, designated STATs 1, 2, 3, 4,
5A, 5B, and 6, which have unique tissue distributions and
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regulate the expression of tissue-specific genes (Darnell
1997). STATexpression and modulation of gene expression
can be cell specific, and transgenic knockout studies have
shown critical roles for every member of the STAT family
(Darnell 1997). The STATs are primarily activated by cyto-
kines and hormones. Ligand binding initiates a cascade
that results in STAT tyrosine phosphorylation, dimeriza-
tion, and translocation to the nucleus, where STATs mod-
ulate transcription (Schindler and Darnell 1995; Darnell
1997). Several groups have established that STATs 1, 3,
5A, 5B, and 6 are expressed in adipocytes. STATs 1, 5A,
and 5B are substantially induced during 3T3-L1 adipocyte
differentiation (Stephens et al. 1996). Similar induction
patterns of STATs 5A and 5B occur in human subcutaneous
preadipocytes (Harp et al. 2001). The studies in mouse and
human cells revealed similar induction of STATs 3, 5A, and
5B, but there was a difference in STAT1 induction in mouse
and human cells. However, it is unlikely that STAT1 plays a
critical role in adipocyte development, because STAT1-
knockout mice do not have any apparent body weight ab-
normalities (Meraz et al. 1996).
Although the relevance for the differential expression of
STAT1 during the adipogenic program remains unclear,
there are several studies that demonstrate a role for STATs
3, 5A, and 5B in human and murine adipogenesis. STAT3
expression increases during the proliferative phase of 3T3-
L1 adipogenesis (Deng et al. 2000), and its expression is
tightly regulated by protein inhibitor of activated STAT3
(PIAS3) (Deng et al. 2006). Inhibition of adipogenesis has
been observed with both AG490, a Janus kinase 2 (JAK2)
inhibitor, and STAT3 siRNAs (Zhang et al. 2011). Addi-
tionally, ectopic expression of a dominant-negative STAT3
suppresses adipocyte differentiation (Wang et al. 2010).
Mice lacking STAT3 in adipose tissue were generated using
the aP2 promoter and had higher body weights and in-
creased adipocyte size compared with wild-type littermates
(Cernkovich et al. 2008). Taken together, these studies sug-
gest a possible role for STAT3 in adipogenesis and body
weight homeostasis. However, additional studies are nec-
essary to further clarify the contribution of STAT3 in adi-
pocyte development and physiology.
The involvement of STAT5 in adipogenesis has been
widely studied. Ectopic expression of C/EBPb and -d in
nonprecursor cells has been shown to induce adipogenesis
(Wu et al. 1996) in a manner that promotes an increase in
STAT5A and STAT5B expression (Stephens et al. 1999).
PPARg has also been shown to up-regulate the expression
of both STAT5 proteins during adipogenesis (Stewart et al.
1999). In 3T3-F442A preadipocytes, the modulating effect
of growth hormone (GH) on adipogenesis is attenuated by
STAT5 antisense oligonucleotides (Yarwood et al. 1999),
and constitutively active STAT5 can drive adipogenesis in
this model system (Shang and Waters 2003). Ectopic ex-
pression studies and transgenic knockout experiments have
confirmed the physiological relevance of STAT5 proteins
in adipogenesis. Ectopic expression of STAT5A induces
adipogenesis in 3T3-L1 preadipocytes (Nanbu-Wakao et
al. 2002) and in two nonprecursor fibroblast cell lines:
BALB/c and NIH-3T3 cells (Floyd and Stephens 2003).
Of note, STAT5B was unable to display similar proadipo-
genic properties in these nonprecursor cells (Floyd and
Stephens 2003). Studies have shown that the GH-activated
STAT5 proteins can induce PPARg expression in 3T3-L1
cells and C3H10T1/2 cells (Kawai et al. 2007), suggesting a
mechanism by which STAT5 proteins are able to promote
adipocyte differentiation. Interestingly, transgenic knock-
out experiments have shown that disruption in either STA-
T5A or STAT5B or both genes resulted in abnormal adipose
tissue, and mice lacking both STAT5 proteins had fat pads
one-fifth the normal size (Teglund et al. 1998). To date
there are no studies on tissue-specific knockout of STAT5
genes in adipocytes, and the phenotype of the STAT5-null
mice could be attributed to developmental effects of STAT5
that are independent of direct effects on preadipocyte dif-
ferentiation. However, recent observations have shown that
ectopic STAT5A expression can confer the adipogenic ca-
pabilities of Swiss 3T3 fibroblasts in athymic mice (Stewart
et al. 2011). In addition to showing a direct role of STAT5A
in preadipocyte differentiation in vivo, these studies also
show the usefulness of athymic mice in studying the role
of transcription factors in adipose tissue development. In
summary, the importance of the STAT5 proteins in adipo-
genesis has been shown in vitro and in the whole animal.
2.4.6 PPARg
There are many proadipogenic transcription factors that
have been characterized, but none are as critical as PPARg,
the master regulator of adipocyte differentiation and gene
expression. Of note, the majority of identified repressors
and activators of adipogenesis have been shown to modu-
late PPARg expression and/or activity. Studies using in
vitro models of adipogenesis have consistently shown that
PPARg mRNA is induced by several transcription factors,
including C/EBPb, C/EBPd, EBF1, and KLF5. Repressors
of adipogenesis such as GATA2, KLF2, and CHOP have
been shown to attenuate PPARg expression (reviewed in
Rosen et al. 2009). PPARg is a member of a superfamily of
hormone nuclear receptors and has been shown to be cru-
cial and sufficient for adipocyte development in vitro and
in vivo (Tontonoz et al. 1994; Hu et al. 1995; Rosen et al.
1999). In 1995 the antidiabetic thiazolidinedione drugs
were shown to be high-affinity PPARg ligands (Lehmann
et al. 1995). This study was the first to indicate that PPARg
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was a target for this antidiabetic class of drugs. PPARg
proteins are expressed in two forms, PPARg1 and PPARg2,
which are produced by a combination of differential pro-
moter usage and alternative splicing (Fajas et al. 1997).
PPARg1 is expressed at low levels in multiple tissues,
whereas PPARg2 is highly expressed in fat cells and dif-
fers from PPARg1 by an amino-terminal extension of 30
amino acids (Tontonoz et al. 1994). A key regulatory role of
PPARg in fat cell differentiation was observed by gain-of-
function experiments that revealed that ectopic expression
and activation of PPARg in fibroblasts or myocytes pro-
moted adipogenesis (Tontonoz et al. 1994; Hu et al. 1995).
Recent studies have shown that PPARg2, but not PPARg1,
profoundly affects adipogenesis (Ren et al. 2002) and that
increases of only PPARg2 were observed in adipocytes of
morbidly obese individuals (Sewter et al. 2002). Although
these studies suggest differential roles of the PPARg iso-
forms, a study in PPARg-null cells showed that both PPARg1
and PPARg2 can stimulate robust adipogenesis (Mueller
et al. 2003). However, PPARg2 shows an enhanced ability
to confer adipogenesis because of its increased sensitivity to
ligands and increased capacity to bind components of the
DRIP/TRAP complex (Mueller et al. 2003).
In vivo studies have shown that PPARg deletion in mice
results in placental dysfunction and embryonic lethality
(Barak et al. 1999). To overcome this developmental limi-
tation, fat-specific knockout mice and mice in which pla-
cental dysfunction was averted were engineered to study the
proadipogenic capabilities of PPARg. The use of these
mouse model systems has shown that PPARg is critical
for fat cell development (Rosen et al. 1999), and mice with
adipose tissue–specific loss of PPARg display decreased fat
pad size and insulin resistance in adipose tissue and liver
(He et al. 2003). Although PPARg is required for adipo-
genesis, there is evidence to suggest that this nuclear recep-
tor may not be needed to maintain the differentiated state
of the cell after adipogenesis (Liao et al. 2007). Of note,
PPARg heterozygote mice show enhanced insulin sensitiv-
ity (Miles et al. 2000), suggesting the amount of protein
present is highly important. The importance of PPARg in
human adipose tissue has also been established, and sub-
jects with mutations in the PPARg gene can develop severe
insulin resistance and lipodystrophy (Barroso et al. 1999;
Doney et al. 2004; Monajemi et al. 2007). Taken together,
these studies show the requirement for PPARg in adipocyte
differentiation and whole-body insulin sensitivity.
The expression and activity of PPARg can be modulat-
ed by various pathways, and several studies in the last dec-
ade have focused on the posttranslational regulation of this
nuclear receptor. In particular, the ubiquitin–proteasome
system has emerged as an important regulator of PPARg
(Hauser et al. 2000; Dennis et al. 2001; Floyd and Stephens
2002). Both the AF-1 and ligand-binding domains (LBDs)
of PPARg are targeted to the proteasome for degradation,
but only the LBD is conjugated to ubiquitin (Kilroy et al.
2009). Of note, a fully functional ubiquitin system is re-
quired for PPARg activation (Kilroy et al. 2009). Overall,
these studies indicate that the ubiquitin–proteasome path-
way is an integral determinant of PPARg activity and that
this nuclear receptor is targeted to the proteasome for deg-
radation via ubiquitin-independent and ubiquitin-depen-
dent mechanisms. Small ubiquitinlike modifier (SUMO), a
protein structurally homologous to ubiquitin, is another
important regulator of PPARg. SUMOylation can occur
in the AF-1 domain at Lys-107 of PPARg2 or Lys-77 of
PPARg1 to control stability and activity (Floyd and Ste-
phens 2004; Ohshima et al. 2004; Yamashita et al. 2004;
Pascual et al. 2005). PPARg can also be SUMOylated in a
ligand-dependent manner in the LBD at Lys-365 (Pascual
et al. 2005). Another regulatory covalent modification of
PPARg is phosphorylation at Ser-112 by mitogen-activated
protein kinases (MAPKs) such as p44/p42 (ERKs 1 and 2)
and c-Jun amino-terminal kinase (JNK), which results in
transcriptional inactivation of PPARg (Camp and Tafuri
1997). Although it is widely accepted that phosphorylation
of PPARg2 inhibits its activity, a point mutation at Ser-112
does not disrupt the ability of PPARg2 to confer adipo-
genesis (Rangwala et al. 2003). However, in vivo studies
have shown that PPARg2 phosphorylation at this residue
modulates insulin sensitivity in the setting of diet-induced
obesity (Rangwala et al. 2003). Recent studies have revealed
that CDK5 phosphorylates PPARg at Ser-273 to attenuate
PPARg trans-activation of important adipocyte genes,
including adiponectin (Choi et al. 2010). The tightly con-
trolled regulation of PPARg by ubiquitylation, SUMOyla-
tion, and phosphorylation indicates the importance of
modulating the expression and activity of this master reg-
ulator of adipogenesis.
3 NEGATIVE EFFECTORS OF ADIPOGENESIS
3.1 Wnt Signaling
The Wnt family is a group of .16 secreted glycoproteins
that has pleiotropic effects on cell-fate specification, pro-
liferation, and differentiation (reviewed in Cadigan and
Nusse 1997). Wnts signal in an autocrine or paracrine
manner through the Frizzled receptors, or low-density li-
poprotein receptor-related protein (reviewed in Bejsovec
2000). Upon binding its Frizzled receptor, Wnt activates
the canonical pathway that inhibits glycogen synthase ki-
nase-3 (GSK3) and results in an increase of cytosolic b-
catenin, then translocates to the nucleus, where it binds to
the T-cell factor/lymphoid-enhancing factor (TCF/LEF)
transcription factors to regulate the expression of Wnt
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target genes (reviewed in Cadigan and Nusse 1997). Micro-
array analyses revealed that Wnt10b and -5a are repressed
during adipogenesis (Ross et al. 2000, 2002). As shown in
Figure 1, Wnt signaling inhibits fat cell differentiation by
reducing the expression of PPARg and C/EBPa in 3T3-L1
and 3T3-F442A cells (Ross et al. 2000; Bennett et al. 2002;
Moldes et al. 2003). Of note, activation of the Wnt pathway
attenuates the expression of brown adipocyte marker genes
UCP1 and PPARg coactivator-1a (PGC-1a), while the ex-
pression of other adipocyte genes is maintained (Kang et al.
2005). To further examine the effects of Wnts on adipo-
genesis, researchers engineered transgenic mice that express
ectopic Wnt10b using the aP2 promoter. These mice had a
50% reduction in WAT and severely reduced BAT. Interest-
ingly, this inhibition of adipose tissue development did not
result in lipodystrophic diabetes, and these mice showed
enhanced insulin sensitivity (Longo et al. 2004).
3.2 GATA Factors
There are six members of this zinc finger domain family of
transcription factors; these are designated GATA1 to -6.
These transcription factors bind to specific (A/T)GA-
TA(A/G) DNA consensus sequences to regulate cellular
differentiation and proliferation (Weiss and Orkin 1995).
Of the six factors, only GATA2 and -3 are expressed in
preadipocytes that are present in WAT but not in BAT
(Tong et al. 2000). The expression of these transcription
factors is repressed during adipocyte differentiation, which
suggests that GATA2 and -3 exert antiadipogenic effects on
preadipocytes (see Fig. 2). In support of this hypothesis,
GATA2-deficient embryonic stem cells exhibit an enhanced
differentiation potential and ectopic expression of GATA2
partially reduces fat cell development by directly binding to
a PPARg promoter region to repress basal activity (Tong
et al. 2000). GATA2 and -3 can also associate with C/EBPa
and -b to disrupt their transcriptional activity (Tong et al.
2005), suggesting that GATA can attenuate adipogenesis
via multiple pathways. GATA proteins can be regulated
posttranslationally byacetylation, SUMOylation, and phos-
phorylation (Boyes et al. 1998; Chun et al. 2003; Menghini
et al. 2005). Akt phosphorylation of GATA results in cyto-
solic sequestering and inhibition of nuclear translocation
(Menghini et al. 2005). Friend of GATA (FOG) and car-
boxy-terminal binding proteins (CTBPs) act together with
GATA2 as coregulators of adipocyte proliferation and dif-
ferentiation (Jack and Crossley 2010).
3.3 KLFs
As indicated above, KLFs 4, 5, 6, and 15 promote adipo-
genesis. However, other members of the KLF family can
inhibit fat cell differentiation. Studies have shown that
KLF2 and KLF7 are negative regulators of fat cell differen-
tiation. KLF2 mRNA is highly expressed in preadipocytes
present in adipose tissue, and its expression is decreased
during adipogenesis. Ectopic expression of KLF2 in 3T3-L1
preadipocytes significantly disrupts lipid accumulation by
repressing PPARg2 gene expression (Banerjee et al. 2003)
and partially restoring Pref-1 expression (Wu et al. 2005).
The effect of KLF2 on adipocyte development is also evi-
dent in mouse embryonic fibroblasts derived from KLF22/2
mouse embryos that show enhanced lipid accumulation
(Wu et al. 2005). Ectopic expression of KLF7, another neg-
ative regulator of adipogenesis in human preadipocytes,
significantly inhibits adipocyte development and expres-
sion of PPARg and C/EBPa (Kawamura et al. 2006).
3.4 Pref-1
Pref-1 was identified in a 3T3-L1 cDNA library for its en-
riched expression in preadipocytes (Smas and Sul 1993).
DLK-1 is the human homolog of Pref-1 and was originally
identified by purification from fetal circulation as fetal an-
tigen-1 (Jensen et al. 1994). Pref-1 is a transmembrane
protein that belongs to a family of EGF-repeat-containing
proteins and shares structural homology with the Notch/
Delta/Serrate proteins (reviewed in Sul 2009). Pref-1 is
activated by proteolytic cleavage to regulate cell-fate spec-
ification (Smas et al. 1997). This protein is abundantly
expressed in preadipocytes, but levels substantially dimin-
ish during adipocyte development (Smas et al. 1998). Con-
stitutive expression of Pref-1 reduces PPARg and C/EBPa
expression and inhibits the differentiation of 3T3-L1 pre-
adipocytes (Smas and Sul 1993). Pref-1-deficient mice
show growth retardation and accelerated adiposity (Moon
et al. 2002). Transgenic mice with aP2-mediated ectopic
expression of Pref-1 in adipose tissue have severe lipoatro-
phy, impaired glucose tolerance, and hypertriglyceridemia
(Lee et al. 2003).
4 ENDOCRINE CONTROL OF ADIPOGENESIS
4.1 Thyroid Hormone
The thyroid hormones, triiodothyronine (T3) and thyrox-
ine (T4), are controlled by a well-studied classic nega-
tive-feedback loop. T3, the biologically active form of the
hormone, has pleiotropic effects on various physiological
processes and is a key regulator of metabolism and devel-
opment. Thyroid hormone action is mediated through a
family of nuclear thyroid hormone receptors that can re-
press transcription in a ligand-independent manner. An
association between thyroid hormone and adipose tissue
development has been established since 1888, when a study
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on myxedema suggested that obesity was a prerequisite for
a diagnosis of hypothyroidism (reviewed in Mariash 2003).
Rodent hyperthyroidism induces adipocyte hyperplasia,
whereas hypothyroidism impedes adipose tissue develop-
ment (Levacher et al. 1984).
It is well-known that T3 induces brown adipocyte dif-
ferentiation. T3-supplemented medium is commonly used
to stimulate differentiation of cultured brown adipocytes
(Klaus et al. 1994). The effect of thyroid hormone on lipo-
genesis has been observed in Sprague-Dawley rats treated
with T3 (Oppenheimer et al. 1991), suggesting that thyroid
hormone can induce the expression of lipogenic genes.
Studies investigating the involvement of thyroid hormones
in adipose tissue development are controversial. To date,
no mechanisms of thyroid hormone action in adipogenesis
have been documented. Nonetheless, it is clear that thy-
roid hormones are capable of regulating adipocyte devel-
opment and modulating the expression of genes required
for lipogenesis.
4.2 Steroid Hormones
Steroid hormones regulate the distribution and develop-
ment of fat in mammals. Hence it is not surprising that
adipocytes express abundant levels of steroid hormone re-
ceptors. The actions of steroid receptors are mediated by
genomic responses and events that are independent of tran-
scription. This section will focus on the effects of estrogen
(E2), androgens, and glucocorticoids on adipocyte differ-
entiation. The receptor-mediated effects of estrogen occur
via two receptors, ER-a and ER-b, to regulate metabolism
and adipose tissue distribution (Wade et al. 1985; Bjorn-
torp 1991). Potential gene targets of E2 can be estimated by
the expression and distribution of its receptors. Studies
investigating the expression patterns of ER-a and ER-b
showed that they are expressed in rat and human preadi-
pocytes, mature adipocytes, and other cell types present in
adipose tissue, including macrophages (Price and O’Brien
1993; Crandall et al. 1998; Dieudonne et al. 2004). Various
studies have shown that E2 regulates adipocyte differenti-
ation; however, the results are contradictory. Estrogen has
been reported to induce the differentiation of 3T3-L1,
female rat subcutaneous fat, and human preadipocytes
(Dieudonne et al. 2000; Anderson et al. 2001). However,
another study showed that estrogen inhibits 3T3-L1 pre-
adipocyte differentiation (Lea-Currie et al. 1999). In vivo
studies have yielded more consistent observations, as
both male and female ER-a-deficient mice have increased
WAT accumulation and insulin resistance (Heine et al.
2000). Studies using E2-deficient rodent models also sup-
ported the inhibitory effect of this hormone on adiposity.
Aromatase-deficient mice (ArKO) develop increased fat
pad mass, hyperinsulinemia, hyperlipidemia, and liver
steatosis (Jones et al. 2000). Mice deficient of follicle-stim-
ulating hormone receptor show increased development of
visceral fat (Danilovich et al. 2000). Collectively, the ma-
jority of studies suggest that estrogen attenuates adipocyte
development.
Androgens also regulate fat cell metabolism and adi-
pose tissue distribution (Wade et al. 1985; Bjorntorp
1991). Androgens can be found in adipocytes (Deslypere
et al. 1985), and there is substantial evidence to show that
the androgen receptor (AR) is expressed in rat (De Pergola
et al. 1990; Dieudonne et al. 1995) and human (Dieudonne
et al. 1998) preadipocytes and adipocytes. Together, these
observations indicate that fat cells are targets of androgen
action. As observed with estrogen experiments, in vitro
studies have shown opposing effects of androgens on the
differentiation of preadipocytes. There is evidence that an-
drogens induce rat fat cell development (Xu and Bjorntorp
1987), whereas others report that androgens inhibit adipo-
cyte differentiation (Gordon et al. 1986; McIntosh et al.
1998; Lea-Currie et al. 1999). It was proposed that the
two potent androgens, testosterone and dihydrotestoster-
one, decrease C/EBPa and PPARg2 expression to inhibit
differentiation of 3T3-L1 cells (Singh et al. 2006). Addi-
tionally, transgenic mice with targeted AR overexpression
in mesenchymal stem cells have substantial reductions in
both WAT and BAT depots (Semirale et al. 2011). In sum-
mary, the majority of studies on androgens and adipocyte
development suggest that these steroid hormones have in-
hibitory effects.
Glucocorticoids are another class of steroid hormones
that regulate adipocyte differentiation. The glucocorticoid
receptor (GR) is expressed in most cell types, and gluco-
corticoids bind to GR to mediate effects on metabolism
and immune response (Vegiopoulos and Herzig 2007). It
is well established that glucocorticoids promote adipogen-
esis. Dexamethasone, a synthetic glucocorticoid, is a stan-
dard component of the hormonal induction cocktail used
to induce 3T3-L1 preadipocyte differentiation (Rubin et al.
1978). Today dexamethasone is used to promote adipo-
genesis in many cell lines, including 10T1/2 (Chapman
et al. 1985) and Ob1771 (Gaillard et al. 1991) cells. Mech-
anistic studies indicate that dexamethasone induces C/
EBPd (Cao et al. 1991), which induces the master adipo-
genic regulator PPARg (Wu et al. 1996).
4.3 Peptide Hormones
A large variety of peptide hormones can modulate adipo-
genesis. Both preadipocytes and adipocytes are responsive
to growth hormone. GH signals primarily via the JAK-
STAT signaling pathway. As indicated earlier in this review,
K. Sarjeant and J.M. Stephens
10 Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008417
Harbor Laboratory Press 
 at LOUISIANA STATE UNIV on September 29, 2021 - Published by Cold Springhttp://cshperspectives.cshlp.org/Downloaded from 
STAT5 proteins promote adipogenesis in vitro and in vivo
(Stephens et al. 1996; Teglund et al. 1998; Harp et al. 2001;
Nanbu-Wakao et al. 2002). Because GH is a potent activa-
tor of STAT5, it is not surprising that most studies show that
GH promotes adipocyte development. The GH-STAT5
pathway enhances both the expression and the activity of
C/EBPb and -d and PPARg (Kawai et al. 2007), thus pro-
posing multiple pathways through which GH promotes
adipogenesis. Earlier studies showed that GH exerts a
dual effect on 3T3-F442A preadipocytes, in which there is
an initial direct effect on preadipocytes to initiate the adi-
pogenic program that is followed by an indirect effect of
GH to induce insulin-like growth factor-1 (IGF-1) to stim-
ulate growth of the committed cells (Green et al. 1985).
Although it has been clearly established that GH promotes
adipocyte development in clonal cell lines, several studies
show an opposing effect of GH action on differentiation of
primary cultured preadipocytes. In primary rat and human
preadipocytes, GH inhibits differentiation (Wabitsch et al.
1996a, 1996b).
It is assumed that insulin is a positive regulator of fat cell
development. However, levels of insulin in the standard
hormonal cocktail are supraphysiological and are capable
of activating IGF-1 receptor signaling (Smith et al. 1988).
Nonetheless, there is evidence that insulin signaling can
modulate the expression of genes required for adipocyte
development and physiology in the whole animal. Mice
that lack the insulin receptor in adipose tissue show re-
duced fat mass and decreased levels of SREBP-1 and C/
EBPa in white adipocytes. Additionally, these mice have
abnormally high leptin serum levels (Bluher et al. 2002).
These studies suggest that insulin can promote adipogen-
esis; however, more studies are necessary to clarify the
mechanism(s) of action.
4.4 Glycoprotein 130 (gp130) Cytokines
The family of gp130 cytokines regulate a variety of complex
biological processes including hematopoiesis, immune re-
sponse, inflammation, proliferation, differentiation, mam-
malian reproduction, cardiovascular action, and neuronal
survival (reviewed in Heinrich et al. 2003). These cyto-
kines share gp130 as a common signal transducer in their
receptor complex and typically activate STAT3, a latent
transcription factor. The gp130 family is also referred to
as the interleukin-6 (IL-6) family of cytokines and is a
group of functionally and structurally related proteins
that includes IL-6, IL-11, IL-27, leukemia inhibitory factor
(LIF), oncostatin M (OSM), ciliary neurotrophic factor
(CNTF), cardiotrophin-1 (CT-1), novel neurotrophin-1/
B-cell-stimulating factor-3 or cardiotrophin-like cytokine
(CLC), and neuropoietin (NP) (reviewed in Fasnacht and
Muller 2008). The gp130 cytokines have become a focus of
attention in the scientific community because they have
been implicated as potential therapeutic targets in obesity
treatment (reviewed in Febbraio 2007). Numerous findings
in the last decade have highlighted the differential effects of
gp130 cytokines on important adipocyte functions. These
studies have shown that adipocytes in vitro and adipose
tissue in vivo are responsive to gp130 cytokines (Balhoff
and Stephens 1998; Stephens et al. 1998; Lagathu et al.
2003; Rotter et al. 2003; Zvonic et al. 2003, 2004; Tenney
et al. 2005; White et al. 2008) and exert differential effects
on adipogenesis. To date, no gp130 cytokines have been
shown to promote adipogenesis, but as shown in Table 1,
several cytokines in this family have been shown to inhibit
adipocyte development (Keller et al. 1993; Meng et al. 2001;
Zvonic et al. 2003, 2004; Sopasakis et al. 2004; Hogan and
Stephens 2005; Miyaoka et al. 2006; Song et al. 2007; White
et al. 2008).
5 ADIPOGENESIS AND METABOLIC
DISEASE STATES
In the past it was widely hypothesized that inhibitors of
adipogenesis were potential antiobesity therapeutics. How-
ever, evidence from a variety of experiments in mice and
humans suggests that inhibitors of adipogenesis are a poor
choice for amelioration of metabolic disease states because
limiting fat cell expansion is associated with insulin resis-
tance. As proposed more than a decade ago, a failure in
adipocyte differentiation can cause type 2 diabetes (Dan-
forth 2000), and this hypothesis is generally recognized and
supported by independent lines of investigation in adipo-
cyte biology.
Inflammation in adipose tissue is widely acknowledged
as a cause of insulin resistance. The presence of infiltrating
immune cells, such as macrophages and T cells, is well
documented, and studies in the last decade suggest that
these cells are modulated in conditions of obesity and
type 2 diabetes. It is well established that the proinflamma-
tory cytokines tumor necrosis factor-a (TNFa) (Torti et al.
1985) and interferon-g (IFNg) (Keay and Grossberg 1980)
are potent inhibitors of adipocyte differentiation. Of note,
it is also known that both of these cytokines induce insulin
resistance in adipocytes (Stephens et al. 1992; McGilli-
cuddy et al. 2009). Both preadipocytes and adipocytes ex-
press receptors for TNFa and IFNg (Fig. 3). Moreover,
TNFa expression is induced in adipose tissue of obese
diabetic rodents (Hotamisligil et al. 1993) and humans
(Hotamisligil et al. 1995). It is now largely accepted that
TNFa expression in adipose tissue comes from macro-
phages (Weisberg et al. 2003). More recent studies have
shown that IFNg is produced from both NK cells (O’Rourke
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et al. 2009) and T cells (Rocha et al. 2008; Duffaut et al.
2009; Strissel et al. 2010; Yang et al. 2010) present in adipose
tissue. Together, these studies suggest that immune cells in
adipose tissue produce TNFa and IFNg, which can inhibit
differentiation of preadipocytes and induce insulin resis-
tance in mature adipocytes. In relation to the Danforth
hypothesis, the induction of type 2 diabetes is believed to
be mediated by the direct effects of TNFa and IFNg on
inducing insulin resistance in mature adipocytes. However,
the ability of these cytokines to induce insulin resistance by
inhibiting adipogenesis has not been considered. Nonethe-
less, there are new model systems that clearly suggest that
limitations in adipose tissue expansion are associated with
insulin resistance. Mice that are very obese but have unlim-
ited adipose tissue expansion are metabolically healthy and
insulin sensitive (Kim et al. 2007). Overall, these studies
largely support Danforth’s idea and indicate that inhibition
of adipogenesis is associated with insulin resistance. With
the recent characterizations of metabolically healthy obese
individuals, it seems clear that obesity is likely preferable
to insulin resistance in terms of overall health. It is also
evident that inhibiting adipogenesis is not a viable thera-
peutic approach.
The role of macrophages and inflammation is less stud-
ied in BAT. There is evidence to suggest minimal macro-
phage infiltration in BAT, just 1% of cells, as compared with
31% observed in WAT (Fitzgibbons et al. 2011). Other
evidence suggests that the presence of anti-inflammatory
macrophages in BAT plays a role in heat production
(Nguyen et al. 2011). Currently there is no consensus on
the amount and function of macrophages and inflamma-
tory mediators in BAT.
6 CONCLUDING REMARKS
The way we view adipocytes has been substantially altered
over the last two decades. Emerging research has changed
our understanding of the origin of adipocytes, and there
is clear evidence that brown and white adipocytes can
arise from distinct precursor cells (see Fig. 2). Adipocytes
are more than inert energy depots, and adipose tissue is
a biologically active organ that carries out important
Table 1. Endocrine modulators of adipogenesis
Class Hormone Effect Model system and references
Steroid hormones Androgen Controversial Proadipogenic in primary tissue cultures (Xu et al. 1987)
Antiadipogenic in 3T3-L1 cells (McIntosh 1990; Lea-Currie et al. 1999)
Inhibits fat development in mice (Semirale et al. 2011)
Estrogen Controversial Proadipogenic in rat preadipocytes (Dieudonne et al. 2000) and human
adipose tissue (Anderson et al. 2001)
Antiadipogenic in 3T3-L1 cells (Lea-Currie et al. 1999) and in various
transgenic mouse models (Danilovich et al. 2000; Heine et al. 2000;
Jones et al. 2000)
Glucocorticoid Proadipogenic Proadipogenic in 3T3-L1 (Cao et al. 1991), 10T1/2 (Semirale et al. 2011),
and Ob1771 cells (Gaillard et al. 1991)
Thyroid Proadipogenic Proadipogenic in HIB 1B brown adipocyte cell line (Klaus et al. 1994)
T3 promotes lipogenesis in rat adipose tissue (Oppenheimer et al. 1991)
Peptide hormones Growth hormone Controversial Proadipogenic in 3T3-L1 cells (Green et al. 1985; Kawai et al. 2007)
Antiadipogenic in primary rat preadipocytes (Wabitsch et al. 1996b) and in
human adipocytes (Wabitsch et al. 1996a)
Insulin/IGF-1 Proadipogenic Proadipogenic in 3T3-L1 cells (Green et al. 1985; Smith et al. 1988)
gp130 cytokines CNTF None No effect on 3T3-L1 adipogenesis (Zvonic et al. 2003)
CT-1 None No effect on 3T3-L1 adipogenesis (Zvonic et al. 2004)
IL-11 Inhibitory Antiadipogenic in 3T3-L1 (Kawashima et al. 1991), human marrow (Keller
et al. 1993), and human preadipocyte cells (Meng et al. 2001)
LTF Controversial No effect on 3T3-L1 adipogenesis (Hogan et al. 2005; White et al. 2008)
Proadipogenic in 3T3-L1 cells (Aubert et al. 1998)
Antiadipogenic in bone marrow stromal cells (Gimble et al. 1994)
NP Inhibitory Antiadipogenic in 3T3-L1 cells (White et al. 2008)
OSM Inhibitory Antiadipogenic in 3T3-L1 cells (Miyaoka et al. 2006; White et al. 2008),
mouse embryonic fibroblasts (Miyaoka et al. 2006), and human
adipose-derived mesenchymal cells (Song et al. 2007)
Abbreviations: IGF-1, insulin-like growth factor-1; CNTF, ciliary neurotrophic factor; CT-1, cardiotrophin-1; IL-11, interleukin-11; LTF, leukemia inhibitory
factor; NP, neuropoietin; OSM, oncostatin M.
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physiological processes including energy homeostasis and
whole-body insulin sensitivity. Attenuating adipose tissue
expansion can result in pathologies including insulin resis-
tance. Several transcription factor families promote adipo-
cyte differentiation, including members of the C/EBP,
STAT, and KLF families (see Fig. 1). However, PPARg is
the most critical transcription factor required for fat cell
development. In fact, most inhibitors of adipogenesis
modulate PPARg expression and/or activity. Adipocyte
development can also be regulated by endocrine factors
including T3, glucocorticoids, GH, and members of the
gp130 cytokine family (see Table 1). However, the overall
effects of these factors on adipogenesis are controversial.
Nonetheless, our knowledge of the source and differentia-
tion of adipocytes has greatly expanded in the last decade as
transcriptional and endocrine modulators of this funda-
mental development process have been identified.
Future studies in the area of adipogenesis will include
the use of sophisticated methodologies to study the cellular
origins of brown and white adipocytes. It is also expected
that there will be extensive investigation of adipose tissue–
derived stem cells for their use as potential therapeutics,
including tissue engineering, as these cells are capable of
differentiating into numerous cell types of both mesoder-
mal and nonmesodermal origin. Given the role of BAT in
energy expenditure, it is highly likely that approaches to
expand BATmass will be used. Current and future research
will also include the generation of highly specific PPARg
ligands that may not only regulate adipocyte development,
but also modulate insulin sensitivity in mature fat cells.
There is little doubt, given the endocrine function of adi-
pose tissue and evidence that inhibition of adipocyte de-
velopment promotes metabolic disease states like type 2
diabetes, that adipocyte development will continue to be
a highly active area of investigation.
REFERENCES
Anderson LA, McTernan PG, Barnett AH, Kumar S. 2001. The effects of
androgens and estrogens on preadipocyte proliferation in human ad-
ipose tissue: Influence of gender and site. J Clin Endocrinol Metab 86:
5045–5051.
Aubert J, Dessolin S, Belmonte N, Li M, McKenzie FR, Staccini L, Vil-
lageois P, Barhanin B, Vernallis A, Smith AG, et al. 1999. Leukemia
inhibitory factor and its receptor promote adipocyte differentiation
via the mitogen-activated protein kinase cascade. J Biol Chem 274:
24965–24972.
Bachman ES, Dhillon H, Zhang CY, Cinti S, Bianco AC, Kobilka BK,
Lowell BB. 2002. bAR signaling required for diet-induced thermogen-
esis and obesity resistance. Science 297: 843–845.
Balhoff JP, Stephens JM. 1998. Highly specific and quantitative activation
of STATs in 3T3-L1 adipocytes. Biochem Biophys Res Commun 247:
894–900.
Banerjee SS, Feinberg MW, Watanabe M, Gray S, Haspel RL, Denkinger






















Lack of TNFα- and IFNγ-producing cells
No inhibition of adipogenesis
insulin sensitivity
Figure 3. Proinflammatory cytokines produced from immune cells in unhealthy adipose tissue inhibit adipocyte
development. The adipocytes in healthy adipose tissue are insulin sensitive, and the tissue does not contain TNFa-
and IFNg-producing cells. The adipocytes in metabolically unhealthy adipose tissue are insulin resistant and lack the
normal ability to expand. The presence of infiltrated immune cells that produce TNFa and IFNg results in inhibition
of adipocyte development.
Adipogenesis
Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008417 13
Harbor Laboratory Press 
 at LOUISIANA STATE UNIV on September 29, 2021 - Published by Cold Springhttp://cshperspectives.cshlp.org/Downloaded from 
KLF2 inhibits peroxisome proliferator-activated receptor-g expression
and adipogenesis. J Biol Chem 278: 2581–2584.
Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder
A, Evans RM. 1999. PPARg is required for placental, cardiac, and
adipose tissue development. Mol Cell 4: 585–595.
Barbatelli G, Murano I, Madsen L, Hao Q, Jimenez M, Kristiansen K,
Giacobino JP, De Matteis R, Cinti S. 2010. The emergence of cold-
induced brown adipocytes in mouse white fat depots is determined
predominantly by white to brown adipocyte transdifferentiation. Am J
Physiol Endocrinol Metab 298: E1244–E1253.
Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA,
Maslen GL, Williams TD, Lewis H, Schafer AJ, O’Rahilly S, et al. 1999.
Dominant negative mutations in human PPARg associated with se-
vere insulin resistance, diabetes mellitus and hypertension. Nature
402: 880–883.
Bejsovec A. 2000. Wnt signaling: An embarrassment of receptors. Curr
Biol 10: R919–R922.
Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW,
Harrison SD, MacDougald OA. 2002. Regulation of Wnt signaling
during adipogenesis. J Biol Chem 277: 30998–31004.
Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. 2001. The adipo-
cyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med
7: 947–953.
Birsoy K, Chen Z, Friedman J. 2008. Transcriptional regulation of adipo-
genesis by KLF4. Cell Metab 7: 339–347.
Bjorntorp P. 1991. Adipose tissue distribution and function. Int J Obes 15
(Suppl 2): 67–81.
Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, Kahn
CR. 2002. Adipose tissue selective insulin receptor knockout protects
against obesity and obesity-related glucose intolerance. Dev Cell 3:
25–38.
Boyes J, Byfield P, Nakatani Y, Ogryzko V. 1998. Regulation of activity of
the transcription factor GATA-1 by acetylation. Nature 396: 594–598.
Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, Spiegelman
BM. 1996. Differential activation of adipogenesis by multiple PPAR
isoforms. Genes Dev 10: 974–984.
Cadigan KM, Nusse R. 1997. Wnt signaling: A common theme in animal
development. Genes Dev 11: 3286–3305.
Camp HS, Tafuri SR. 1997. Regulation of peroxisome proliferator-acti-
vated receptor g activity by mitogen-activated protein kinase. J Biol
Chem 272: 10811–10816.
Cannon B, Hedin A, Nedergaard J. 1982. Exclusive occurrence of ther-
mogenin antigen in brown adipose tissue. FEBS Lett 150: 129–132.
Cao Z, Umek RM, McKnight SL. 1991. Regulated expression of three C/
EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:
1538–1552.
Cernkovich ER, Deng J, Bond MC, Combs TP, Harp JB. 2008. Adipose-
specific disruption of signal transducer and activator of transcription 3
increases body weight and adiposity. Endocrinology 149: 1581–1590.
Chapman AB, Knight DM, Ringold GM. 1985. Glucocorticoid regula-
tion of adipocyte differentiation: Hormonal triggering of the devel-
opmental program and induction of a differentiation-dependent gene.
J Cell Biol 101: 1227–1235.
Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. 2003.
Adiponectin stimulates production of nitric oxide in vascular endo-
thelial cells. J Biol Chem 278: 45021–45026.
Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, Laznik D, Ruas JL,
Chalmers MJ, Kamenecka TM, Bluher M, et al. 2010. Anti-diabetic
drugs inhibit obesity-linked phosphorylation of PPARg by Cdk5. Na-
ture 466: 451–456.
Chun TH, Itoh H, Subramanian L, Iniguez-Lluhi JA, Nakao K. 2003.
Modification of GATA-2 transcriptional activity in endothelial cells by
the SUMO E3 ligase PIASy. Circ Res 92: 1201–1208.
Cinti S. 2005. The adipose organ. Prostaglandins Leukot Essent Fatty Acids
73: 9–15.
Colotta F, Polentarutti N, Sironi M, Mantovani A. 1992. Expression and
involvement of c-fos and c-jun protooncogenes in programmed cell
death induced by growth factor deprivation in lymphoid cell lines. J
Biol Chem 267: 18278–18283.
Cousin B, Cinti S, Morroni M, Raimbault S, Ricquier D, Penicaud L,
Casteilla L. 1992. Occurrence of brown adipocytes in rat white adipose
tissue: Molecular and morphological characterization. J Cell Sci 103
(Pt 4): 931–942.
Crandall DL, Busler DE, Novak TJ, Weber RV, Kral JG. 1998. Identifica-
tion of estrogen receptor b RNA in human breast and abdominal
subcutaneous adipose tissue. Biochem Biophys Res Commun 248:
523–526.
Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo
FC, Palmer EL, Tseng YH, Doria A, et al. 2009. Identification and
importance of brown adipose tissue in adult humans. N Engl J Med
360: 1509–1517.
Danforth E Jr. 2000. Failure of adipocyte differentiation causes type II
diabetes mellitus? Nat Genet 26: 13.
Dang DT, Pevsner J, Yang VW. 2000. The biology of the mammalian
Kruppel-like family of transcription factors. Int J Biochem Cell Biol
32: 1103–1121.
Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam
MR. 2000. Estrogen deficiency, obesity, and skeletal abnormalities in
follicle-stimulating hormone receptor knockout (FORKO) female
mice. Endocrinology 141: 4295–4308.
Darnell JE Jr. 1997. STATs and gene regulation. Science 277: 1630–1635.
Deng J, Hua K, Lesser SS, Harp JB. 2000. Activation of signal transducer
and activator of transcription-3 during proliferative phases of 3T3-L1
adipogenesis. Endocrinology 141: 2370–2376.
Deng J, Hua K, Caveney EJ, Takahashi N, Harp JB. 2006. Protein inhibitor
of activated STAT3 inhibits adipogenic gene expression. Biochem Bio-
phys Res Commun 339: 923–931.
Dennis AP, Haq RU, Nawaz Z. 2001. Importance of the regulation of
nuclear receptor degradation. Front Biosci 6: D954–D959.
De Pergola G, Xu XF, Yang SM, Giorgino R, Bjorntorp P. 1990. Up-
regulation of androgen receptor binding in male rat fat pad adipose
precursor cells exposed to testosterone: Study in a whole cell assay
system. J Steroid Biochem Mol Biol 37: 553–558.
Deslypere JP, Verdonck L, Vermeulen A. 1985. Fat tissue: A steroid res-
ervoir and site of steroid metabolism. J Clin Endocrinol Metab 61:
564–570.
Dieudonne MN, Pecquery R, Leneveu MC, Jaubert AM, Giudicelli Y.
1995. Androgen receptors in cultured rat adipose precursor cells dur-
ing proliferation and differentiation: Regional specificities and regu-
lation by testosterone. Endocrine 3: 537–541.
Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y.
1998. Androgen receptors in human preadipocytes and adipocytes:
Regional specificities and regulation by sex steroids. Am J Physiol 274:
C1645–C1652.
Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y. 2000. Opposite
effects of androgens and estrogens on adipogenesis in rat preadipo-
cytes: Evidence for sex and site-related specificities and possible in-
volvement of insulin-like growth factor 1 receptor and peroxisome
proliferator-activated receptor g2. Endocrinology 141: 649–656.
Dieudonne MN, Leneveu MC, Giudicelli Y, Pecquery R. 2004. Evidence
for functional estrogen receptors a and b in human adipose cells:
Regional specificities and regulation by estrogens. Am J Physiol Cell
Physiol 286: C655–C661.
Distel RJ, Ro HS, Rosen BS, Groves DL, Spiegelman BM. 1987. Nucleo-
protein complexes that regulate gene expression in adipocyte differ-
entiation: Direct participation of c-fos. Cell 49: 835–844.
Doney AS, Fischer B, Leese G, Morris AD, Palmer CN. 2004. Cardiovas-
cular risk in type 2 diabetes is associated with variation at the PPARG
locus: A Go-DARTS study. Arterioscler Thromb Vasc Biol 24: 2403–
2407.
Duffaut C, Zakaroff-Girard A, Bourlier V, Decaunes P, Maumus M,
Chiotasso P, Sengenes C, Lafontan M, Galitzky J, Bouloumie A.
2009. Interplay between human adipocytes and T lymphocytes in
K. Sarjeant and J.M. Stephens
14 Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008417
Harbor Laboratory Press 
 at LOUISIANA STATE UNIV on September 29, 2021 - Published by Cold Springhttp://cshperspectives.cshlp.org/Downloaded from 
obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic
modulators. Arterioscler Thromb Vasc Biol 29: 1608–1614.
Enerback S. 2009. The origins of brown adipose tissue. N Engl J Med 360:
2021–2023.
Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R,
Najib J, Laville M, Fruchart JC, Deeb S, et al. 1997. The organization,
promoter analysis, and expression of the human PPARg gene. J Biol
Chem 272: 18779–18789.
Farmer SR. 2008. Molecular determinants of brown adipocyte formation
and function. Genes Dev 22: 1269–1275.
Fasnacht N, Muller W. 2008. Conditional gp130 deficient mouse mu-
tants. Semin Cell Dev Biol 19: 379–384.
Febbraio MA. 2007. gp130 receptor ligands as potential therapeutic tar-
gets for obesity. J Clin Invest 117: 841–849.
Fitzgibbons TP, Kogan S, Aouadi M, Hendricks GM, Straubhaar J, Czech
MP. 2011. Similarity of mouse perivascular and brown adipose tissues
and their resistance to diet-induced inflammation. Am J Physiol Heart
Circ Physiol 301: H1425–H1427.
Flodby P, Barlow C, Kylefjord H, Ahrlund-Richter L, Xanthopoulos KG.
1996. Increased hepatic cell proliferation and lung abnormalities in
mice deficient in CCAAT/enhancer binding protein a. J Biol Chem
271: 24753–24760.
Floyd ZE, Stephens JM. 2002. Interferon-g-mediated activation and
ubiquitin-proteasome-dependent degradation of PPARg in adipo-
cytes. J Biol Chem 277: 4062–4068.
Floyd ZE, Stephens JM. 2003. STAT5A promotes adipogenesis in non-
precursor cells and associates with the glucocorticoid receptor during
adipocyte differentiation. Diabetes 52: 308–314.
Floyd ZE, Stephens JM. 2004. Control of peroxisome proliferator-acti-
vated receptor g2 stability and activity by SUMOylation. Obes Res 12:
921–928.
Freytag SO, Paielli DL, Gilbert JD. 1994. Ectopic expression of the
CCAAT/enhancer-binding protein a promotes the adipogenic pro-
gram in a variety of mouse fibroblastic cells. Genes Dev 8: 1654–1663.
Gaillard D, Wabitsch M, Pipy B, Negrel R. 1991. Control of terminal
differentiation of adipose precursor cells by glucocorticoids. J Lipid
Res 32: 569–579.
Geloen A, Roy PE, Bukowiecki LJ. 1989. Regression of white adipose
tissue in diabetic rats. Am J Physiol 257: E547–E553.
Ghorbani M, Himms-Hagen J. 1997. Appearance of brown adipocytes in
white adipose tissue during CL 316,243-induced reversal of obesity
and diabetes in Zucker fa/fa rats. Int J Obes Relat Metab Disord 21:
465–475.
Gimble JM, Wanker F, Wang CS, Bass H, Wu X, Kelly K, Yancopoulos GD,
Hill MR. 1994. Regulation of bone marrow stromal cell differentiation
by cytokines whose receptors share the gp130 protein. J Cell Biochem
54: 122–133.
Golozoubova V, Hohtola E, Matthias A, Jacobsson A, Cannon B, Neder-
gaard J. 2001. Only UCP1 can mediate adaptive nonshivering ther-
mogenesis in the cold. FASEB J 15: 2048–2050.
Gordon GB, Newitt JA, Shantz LM, Weng DE, Talalay P. 1986. Inhibition
of the conversion of 3T3 fibroblast clones to adipocytes by dehydroe-
piandrosterone and related anticarcinogenic steroids. Cancer Res 46:
3389–3395.
Gray S, Feinberg MW, Hull S, Kuo CT, Watanabe M, Sen-Banerjee S,
DePina A, Haspel R, Jain MK. 2002. The Kruppel-like factor KLF15
regulates the insulin-sensitive glucose transporter GLUT4. J Biol Chem
277: 34322–34328.
Green H, Kehinde O. 1976. Spontaneous heritable changes leading to
increased adipose conversion in 3T3 cells. Cell 7: 105–113.
Green H, Kehinde O. 1979. Formation of normally differentiated sub-
cutaneous fat pads by an established preadipose cell line. J Cell Physiol
101: 169–171.
Green H, Meuth M. 1974. An established pre-adipose cell line and its
differentiation in culture. Cell 3: 127–133.
Green H, Morikawa M, Nixon T. 1985. A dual effector theory of growth-
hormone action. Differentiation 29: 195–198.
Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP. 1998. Emergence of
brown adipocytes in white fat in mice is under genetic control. Effects
on body weight and adiposity. J Clin Invest 102: 412–420.
Harp JB, Franklin D, Vanderpuije AA, Gimble JM. 2001. Differential
expression of signal transducers and activators of transcription during
human adipogenesis. Biochem Biophys Res Commun 281: 907–912.
Hauser S, Adelmant G, Sarraf P, Wright HM, Mueller E, Spiegelman BM.
2000. Degradation of the peroxisome proliferator-activated receptor g
is linked to ligand-dependent activation. J Biol Chem 275: 18527–
18533.
He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E,
Olefsky JM, Evans RM. 2003. Adipose-specific peroxisome prolifera-
tor-activated receptor g knockout causes insulin resistance in fat and
liver but not in muscle. Proc Natl Acad Sci 100: 15712–15717.
Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. 2000. In-
creased adipose tissue in male and female estrogen receptor-a knock-
out mice. Proc Natl Acad Sci 97: 12729–12734.
Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G,
Schaper F. 2003. Principles of interleukin (IL)-6-type cytokine signal-
ling and its regulation. Biochem J 374: 1–20.
Himms-Hagen J, Melnyk A, Zingaretti MC, Ceresi E, Barbatelli G, Cinti
S. 2000. Multilocular fat cells in WATof CL-316243-treated rats derive
directly from white adipocytes. Am J Physiol Cell Physiol 279: C670–
C681.
Hogan JC, Stephens JM. 2005. Effects of leukemia inhibitory factor on
3T3-L1 adipocytes. J Endocrinol 185: 485–496.
Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W,
Nelson C, Lowman HB, Wright BD, Skelton NJ, et al. 2000. FIZZ1, a
novel cysteine-rich secreted protein associated with pulmonary in-
flammation, defines a new gene family. EMBO J 19: 4046–4055.
Horton JD, Shimomura I, Brown MS, Hammer RE, Goldstein JL, Shi-
mano H. 1998. Activation of cholesterol synthesis in preference to fatty
acid synthesis in liver and adipose tissue of transgenic mice overpro-
ducing sterol regulatory element-binding protein-2. J Clin Invest 101:
2331–2339.
Hotamisligil GS, Shargill NS, Spiegelman BM. 1993. Adipose expression
of tumor necrosis factor-a: Direct role in obesity-linked insulin resis-
tance. Science 259: 87–91.
Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. 1995.
Increased adipose tissue expression of tumor necrosis factor-a in hu-
man obesity and insulin resistance. J Clin Invest 95: 2409–2415.
Hu E, Tontonoz P, Spiegelman BM. 1995. Transdifferentiation of myo-
blasts by the adipogenic transcription factors PPARg and C/EBPa.
Proc Natl Acad Sci 92: 9856–9860.
Hu E, Liang P, Spiegelman BM. 1996. AdipoQ is a novel adipose-specific
gene dysregulated in obesity. J Biol Chem 271: 10697–10703.
Hua X, Wu J, Goldstein JL, Brown MS, Hobbs HH. 1995. Structure of the
human gene encoding sterol regulatory element binding protein-1
(SREBF1) and localization of SREBF1 and SREBF2 to chromosomes
17p11.2 and 22q13. Genomics 25: 667–673.
Huttunen P, Hirvonen J, Kinnula V. 1981. The occurrence of brown
adipose tissue in outdoor workers. Eur J Appl Physiol Occup Physiol
46: 339–345.
Inuzuka H, Wakao H, Masuho Y, Muramatsu MA, Tojo H, Nanbu-Wakao
R. 1999. cDNA cloning and expression analysis of mouse zf9, a Krup-
pel-like transcription factor gene that is induced by adipogenic
hormonal stimulation in 3T3-L1 cells. Biochim Biophys Acta 1447:
199–207.
Ishibashi J, Seale P. 2010. Medicine. Beige can be slimming. Science 328:
1113–1114.
Jack BH, Crossley M. 2010. GATA proteins work together with friend of
GATA (FOG) and C-terminal binding protein (CTBP) co-regulators
to control adipogenesis. J Biol Chem 285: 32405–32414.
Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. 2002. Resistin gene
expression in human adipocytes is not related to insulin resistance.
Obes Res 10: 1–5.
Adipogenesis
Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008417 15
Harbor Laboratory Press 
 at LOUISIANA STATE UNIV on September 29, 2021 - Published by Cold Springhttp://cshperspectives.cshlp.org/Downloaded from 
Jensen CH, Krogh TN, Hojrup P, Clausen PP, Skjodt K, Larsson LI,
Enghild JJ, Teisner B. 1994. Protein structure of fetal antigen 1
(FA1). A novel circulating human epidermal-growth-factor-like pro-
tein expressed in neuroendocrine tumors and its relation to the gene
products of dlk and pG2. Eur J Biochem 225: 83–92.
Johnson R, Spiegelman B, Hanahan D, Wisdom R. 1996. Cellular trans-
formation and malignancy induced by ras require c-jun. Mol Cell Biol
16: 4504–4511.
Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J,
Oz OK, Leury BJ, Robertson KM, Yao S, et al. 2000. Aromatase-defi-
cient (ArKO) mice have a phenotype of increased adiposity. Proc Natl
Acad Sci 97: 12735–12740.
Kajimura S, Seale P, Tomaru T, Erdjument-Bromage H, Cooper MP, Ruas
JL, Chin S, Tempst P, Lazar MA, Spiegelman BM. 2008. Regulation of
the brown and white fat gene programs through a PRDM16/CtBP
transcriptional complex. Genes Dev 22: 1397–1409.
Kang S, Bajnok L, Longo KA, Petersen RK, Hansen JB, Kristiansen K,
MacDougald OA. 2005. Effects of Wnt signaling on brown adipocyte
differentiation and metabolism mediated by PGC-1a. Mol Cell Biol
25: 1272–1282.
Kawai M, Namba N, Mushiake S, Etani Y, Nishimura R, Makishima M,
Ozono K. 2007. Growth hormone stimulates adipogenesis of 3T3-L1
cells through activation of the Stat5A/5B-PPARg pathway. J Mol En-
docrinol 38: 19–34.
Kawamura Y, Tanaka Y, Kawamori R, Maeda S. 2006. Overexpression of
Kruppel-like factor 7 regulates adipocytokine gene expressions in hu-
man adipocytes and inhibits glucose-induced insulin secretion in
pancreatic b-cell line. Mol Endocrinol 20: 844–856.
Kawashima I, Ohsumi J, Mita-Honjo K, Shimoda-Takano K, Ishikawa H,
Sakakibara S, Miyadai K, Takiguchi Y. 1991. Molecular cloning of
cDNA encoding adipogenesis inhibitory factor and identity with in-
terleukin-11. FEBS Lett 283: 199–202.
Keay S, Grossberg SE. 1980. Interferon inhibits the conversion of 3T3-L1
mouse fibroblasts into adipocytes. Proc Natl Acad Sci 77: 4099–4103.
Keller DC, Du XX, Srour EF, Hoffman R, Williams DA. 1993. Interleukin-
11 inhibits adipogenesis and stimulates myelopoiesis in human long-
term marrow cultures. Blood 82: 1428–1435.
Kilroy GE, Zhang X, Floyd ZE. 2009. PPAR-gAF-2 domain functions as a
component of a ubiquitin-dependent degradation signal. Obesity (Sil-
ver Spring) 17: 665–673.
Kim JB, Spiegelman BM. 1996. ADD1/SREBP1 promotes adipocyte dif-
ferentiation and gene expression linked to fatty acid metabolism.
Genes Dev 10: 1096–1107.
Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM,
Schraw T, Durand JL, Li H, Li G, et al. 2007. Obesity-associated im-
provements in metabolic profile through expansion of adipose tissue. J
Clin Invest 117: 2621–2637.
Klaus S, Choy L, Champigny O, Cassard-Doulcier AM, Ross S, Spiegel-
man B, Ricquier D. 1994. Characterization of the novel brown adipo-
cyte cell line HIB 1B. Adrenergic pathways involved in regulation of
uncoupling protein gene expression. J Cell Sci 107 (Pt 1): 313–319.
Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H,
Takamoto I, Okamoto S, Shiuchi T, et al. 2007. Adiponectin stimulates
AMP-activated protein kinase in the hypothalamus and increases food
intake. Cell Metab 6: 55–68.
Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M. 2003.
Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and
induced insulin resistance in adipocyte: Prevention by rosiglitazone.
Biochem Biophys Res Commun 311: 372–379.
Lea-Currie YR, Monroe D, McIntosh MK. 1999. Dehydroepiandroster-
one and related steroids alter 3T3-L1 preadipocyte proliferation and
differentiation. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol
123: 17–25.
Lee K, Villena JA, Moon YS, Kim KH, Lee S, Kang C, Sul HS. 2003.
Inhibition of adipogenesis and development of glucose intolerance
by soluble preadipocyte factor-1 (Pref-1). J Clin Invest 111: 453–461.
Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM,
Kliewer SA. 1995. An antidiabetic thiazolidinedione is a high affinity
ligand for peroxisome proliferator-activated receptor g (PPARg). J
Biol Chem 270: 12953–12956.
Levacher C, Sztalryd C, Kinebanyan MF, Picon L. 1984. Effects of thyroid
hormones on adipose tissue development in Sherman and Zucker rats.
Am J Physiol 246: C50–C56.
Li D, Yea S, Li S, Chen Z, Narla G, Banck M, Laborda J, Tan S, Friedman
JM, Friedman SL, et al. 2005. Kruppel-like factor-6 promotes preadi-
pocyte differentiation through histone deacetylase 3-dependent re-
pression of DLK1. J Biol Chem 280: 26941–26952.
Liao W, Nguyen MT, Yoshizaki T, Favelyukis S, Patsouris D, Imamura T,
Verma IM, Olefsky JM. 2007. Suppression of PPAR-g attenuates
insulin-stimulated glucose uptake by affecting both GLUT1 and
GLUT4 in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 293:
E219–E227.
Longo KA, Wright WS, Kang S, Gerin I, Chiang SH, Lucas PC, Opp MR,
MacDougald OA. 2004. Wnt10b inhibits development of white and
brown adipose tissues. J Biol Chem 279: 35503–35509.
MacDougald OA, Lane MD. 1995. Transcriptional regulation of gene
expression during adipocyte differentiation. Annu Rev Biochem 64:
345–373.
Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara
K. 1996. cDNA cloning and expression of a novel adipose specific
collagen-like factor, apM1 (adipose Most abundant gene transcript
1). Biochem Biophys Res Commun 221: 286–289.
Majka SM, Fox KE, Psilas JC, Helm KM, Childs CR, Acosta AS, Janssen
RC, Friedman JE, Woessner BT, Shade TR, et al. 2010. De novo gen-
eration of white adipocytes from the myeloid lineage via mesenchymal
intermediates is age, adipose depot, and gender specific. Proc Natl
Acad Sci 107: 14781–14786.
Mandrup S, Loftus TM, MacDougald OA, Kuhajda FP, Lane MD. 1997.
Obese gene expression at in vivo levels by fat pads derived from s.c.
implanted 3T3-F442A preadipocytes. Proc Natl Acad Sci 94: 4300–
4305.
Mariash CN. 2003. Thyroid hormone and the adipocyte. J Clin Endo-
crinol Metab 88: 5603–5604.
McGillicuddy FC, Chiquoine EH, Hinkle CC, Kim RJ, Shah R, Roche
HM, Smyth EM, Reilly MP. 2009. Interferon g attenuates insulin
signaling, lipid storage, and differentiation in human adipocytes
via activation of the JAK/STAT pathway. J Biol Chem 284: 31936–
31944.
McIntosh M, Hausman D, Martin R, Hausman G. 1998. Dehydroepian-
drosterone attenuates preadipocyte growth in primary cultures of stro-
mal-vascular cells. Am J Physiol 275: E285–E293.
Meng L, Zhou J, Sasano H, Suzuki T, Zeitoun KM, Bulun SE. 2001.
Tumor necrosis factor a and interleukin 11 secreted by malignant
breast epithelial cells inhibit adipocyte differentiation by selectively
down-regulating CCAAT/enhancer binding protein a and peroxi-
some proliferator-activated receptor g: Mechanism of desmoplastic
reaction. Cancer Res 61: 2250–2255.
Menghini R, Marchetti V, Cardellini M, Hribal ML, Mauriello A, Lauro
D, Sbraccia P, Lauro R, Federici M. 2005. Phosphorylation of GATA2
by Akt increases adipose tissue differentiation and reduces adipose
tissue-related inflammation: A novel pathway linking obesity to ath-
erosclerosis. Circulation 111: 1946–1953.
Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan
DH, Riley JK, Greenlund AC, Campbell D, et al. 1996. Targeted dis-
ruption of the Stat1 gene in mice reveals unexpected physiologic spe-
cificity in the JAK-STAT signaling pathway. Cell 84: 431–442.
Miles PD, Barak Y, He W, Evans RM, Olefsky JM. 2000. Improved insulin-
sensitivity in mice heterozygous for PPAR-g deficiency. J Clin Invest
105: 287–292.
Miyaoka Y, Tanaka M, Naiki T, Miyajima A. 2006. Oncostatin M inhibits
adipogenesis through the RAS/ERK and STAT5 signaling pathways. J
Biol Chem 281: 37913–37920.
K. Sarjeant and J.M. Stephens
16 Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008417
Harbor Laboratory Press 
 at LOUISIANA STATE UNIV on September 29, 2021 - Published by Cold Springhttp://cshperspectives.cshlp.org/Downloaded from 
Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Feigenbaum L,
Lee E, Aoyama T, Eckhaus M, Reitman ML, et al. 1998. Life without
white fat: A transgenic mouse. Genes Dev 12: 3168–3181.
Moldes M, Zuo Y, Morrison RF, Silva D, Park BH, Liu J, Farmer SR. 2003.
Peroxisome-proliferator-activated receptor g suppresses Wnt/b-cat-
enin signalling during adipogenesis. Biochem J 376: 607–613.
Monajemi H, Zhang L, Li G, Jeninga EH, Cao H, Maas M, Brouwer CB,
Kalkhoven E, Stroes E, Hegele RA, et al. 2007. Familial partial lipodys-
trophy phenotype resulting from a single-base mutation in deoxyri-
bonucleic acid-binding domain of peroxisome proliferator-activated
receptor-g. J Clin Endocrinol Metab 92: 1606–1612.
Moon YS, Smas CM, Lee K, Villena JA, Kim KH, Yun EJ, Sul HS. 2002.
Mice lacking paternally expressed Pref-1/Dlk1 display growth retar-
dation and accelerated adiposity. Mol Cell Biol 22: 5585–5592.
Mori T, Sakaue H, Iguchi H, Gomi H, Okada Y, Takashima Y, Nakamura
K, Nakamura T, Yamauchi T, Kubota N, et al. 2005. Role of Kruppel-
like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J
Biol Chem 280: 12867–12875.
Moustaid N, Lasnier F, Hainque B, Quignard-Boulange A, Pairault J.
1990. Analysis of gene expression during adipogenesis in 3T3-F442A
preadipocytes: Insulin and dexamethasone control. J Cell Biochem 42:
243–254.
Mueller C, Weaver V, Vanden Heuvel JP, August A, Cantorna MT. 2003.
Peroxisome proliferator-activated receptor g ligands attenuate immu-
nological symptoms of experimental allergic asthma. Arch Biochem
Biophys 418: 186–196.
Nagaev I, Smith U. 2001. Insulin resistance and type 2 diabetes are not
related to resistin expression in human fat cells or skeletal muscle.
Biochem Biophys Res Commun 285: 561–564.
Nanbu-Wakao R, Morikawa Y, Matsumura I, Masuho Y, Muramatsu MA,
Senba E, Wakao H. 2002. Stimulation of 3T3-L1 adipogenesis by signal
transducer and activator of transcription 5. Mol Endocrinol 16:
1565–1576.
Nedergaard J, Bengtsson T, Cannon B. 2007. Unexpected evidence for
active brown adipose tissue in adult humans. Am J Physiol Endocrinol
Metab 293: E444–E452.
Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, Mukundan L,
Brombacher F, Locksley RM, Chawla A. 2011. Alternatively activated
macrophages produce catecholamines to sustain adaptive thermogen-
esis. Nature 480: 104–108.
Novikoff AB, Novikoff PM, Rosen OM, Rubin CS. 1980. Organelle rela-
tionships in cultured 3T3-L1 preadipocytes. J Cell Biol 87: 180–196.
O’Rourke RW, Metcalf MD, White AE, Madala A, Winters BR, Maizlin II,
Jobe BA, Roberts CT Jr, Slifka MK, Marks DL. 2009. Depot-specific
differences in inflammatory mediators and a role for NK cells and
IFN-g in inflammation in human adipose tissue. Int J Obes (Lond)
33: 978–990.
Ohshima T, Koga H, Shimotohno K. 2004. Transcriptional activity of
peroxisome proliferator-activated receptor g is modulated by SUMO-
1 modification. J Biol Chem 279: 29551–29557.
Oishi Y, Manabe I, Tobe K, Tsushima K, Shindo T, Fujiu K, Nishimura G,
Maemura K, Yamauchi T, Kubota N, et al. 2005. Kruppel-like tran-
scription factor KLF5 is a key regulator of adipocyte differentiation.
Cell Metab 1: 27–39.
Oppenheimer JH, Schwartz HL, Lane JT, Thompson MP. 1991. Func-
tional relationship of thyroid hormone-induced lipogenesis, lipolysis,
and thermogenesis in the rat. J Clin Invest 87: 125–132.
Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW,
Willson TM, Rosenfeld MG, Glass CK. 2005. A SUMOylation-depen-
dent pathway mediates transrepression of inflammatory response
genes by PPAR-g. Nature 437: 759–763.
Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton
C, Macphee CH, Smith SA. 2003. Resistin is expressed in human
macrophages and directly regulated by PPARg activators. Biochem
Biophys Res Commun 300: 472–476.
Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B, Neder-
gaard J. 2010. Chronic peroxisome proliferator-activated receptor g
(PPARg) activation of epididymally derived white adipocyte cultures
reveals a population of thermogenically competent, UCP1-containing
adipocytes molecularly distinct from classic brown adipocytes. J Biol
Chem 285: 7153–7164.
Price TM, O’Brien SN. 1993. Determination of estrogen receptor mes-
senger ribonucleic acid (mRNA) and cytochrome P450 aromatase
mRNA levels in adipocytes and adipose stromal cells by competitive
polymerase chain reaction amplification. J Clin Endocrinol Metab 77:
1041–1045.
Qatanani M, Szwergold NR, Greaves DR, Ahima RS, Lazar MA. 2009.
Macrophage-derived human resistin exacerbates adipose tissue in-
flammation and insulin resistance in mice. J Clin Invest 119: 531–539.
Rangwala SM, Rhoades B, Shapiro JS, Rich AS, Kim JK, Shulman GI,
Kaestner KH, Lazar MA. 2003. Genetic modulation of PPARg phos-
phorylation regulates insulin sensitivity. Dev Cell 5: 657–663.
Ren D, Collingwood TN, Rebar EJ, Wolffe AP, Camp HS. 2002. PPARg
knockdown by engineered transcription factors: Exogenous PPARg2
but not PPARg1 reactivates adipogenesis. Genes Dev 16: 27–32.
Reznikoff CA, Brankow DW, Heidelberger C. 1973. Establishment and
characterization of a cloned line of C3H mouse embryo cells sensitive
to postconfluence inhibition of division. Cancer Res 33: 3231–3238.
Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH,
Libby P. 2008. Interferon-g, a Th1 cytokine, regulates fat inflamma-
tion: A role for adaptive immunity in obesity. Circ Res 103: 467–476.
Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegel-
man BM, Mortensen RM. 1999. PPARg is required for the differenti-
ation of adipose tissue in vivo and in vitro. Mol Cell 4: 611–617.
Rosen E, Eguchi J, Xu Z. 2009. Transcriptional targets in adipocyte biol-
ogy. Expert Opin Ther Targets 13: 975–986.
Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL,
MacDougald OA. 2000. Inhibition of adipogenesis by Wnt signaling.
Science 289: 950–953.
Ross SE, Erickson RL, Gerin I, DeRose PM, Bajnok L, Longo KA, Misek
DE, Kuick R, Hanash SM, Atkins KB, et al. 2002. Microarray analyses
during adipogenesis: Understanding the effects of Wnt signaling on
adipogenesis and the roles of liver X receptor a in adipocyte metab-
olism. Mol Cell Biol 22: 5989–5999.
Rossmeisl M, Barbatelli G, Flachs P, Brauner P, Zingaretti MC, Marelli M,
Janovska P, Horakova M, Syrovy I, Cinti S, et al. 2002. Expression of the
uncoupling protein 1 from the aP2 gene promoter stimulates mito-
chondrial biogenesis in unilocular adipocytes in vivo. Eur J Biochem
269: 19–28.
Rotter V, Nagaev I, Smith U. 2003. Interleukin-6 (IL-6) induces insulin
resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis
factor-a, overexpressed in human fat cells from insulin-resistant sub-
jects. J Biol Chem 278: 45777–45784.
Rubin CS, Hirsch A, Fung C, Rosen OM. 1978. Development of hormone
receptors and hormonal responsiveness in vitro. Insulin receptors and
insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1
cells. J Biol Chem 253: 7570–7578.
Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV,
O’Rahilly S. 2001. Resistin/Fizz3 expression in relation to obesity and
peroxisome proliferator-activated receptor-g action in humans. Dia-
betes 50: 2199–2202.
Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. 1995. A novel
serum protein similar to C1q, produced exclusively in adipocytes. J
Biol Chem 270: 26746–26749.
Schindler C, Darnell JE Jr. 1995. Transcriptional responses to polypeptide
ligands: The JAK-STAT pathway. Annu Rev Biochem 64: 621–651.
Schuh R, Aicher W, Gaul U, Cote S, Preiss A, Maier D, Seifert E, Nauber
U, Schroder C, Kemler R, et al. 1986. A conserved family of nuclear
proteins containing structural elements of the finger protein encoded
by Kruppel, a Drosophila segmentation gene. Cell 47: 1025–1032.
Seale P, Kajimura S, Yang W, Chin S, Rohas LM, Uldry M, Tavernier G,
Langin D, Spiegelman BM. 2007. Transcriptional control of brown fat
determination by PRDM16. Cell Metab 6: 38–54.
Adipogenesis
Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008417 17
Harbor Laboratory Press 
 at LOUISIANA STATE UNIV on September 29, 2021 - Published by Cold Springhttp://cshperspectives.cshlp.org/Downloaded from 
Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scime A, Devar-
akonda S, Conroe HM, Tempst P, et al. 2008. PRDM16 controls a
brown fat/skeletal muscle switch. Nature 454: 961–967.
Seale P, Conroe HM, Estall J, Kajimura S, Frontini A, Ishibashi J, Cohen P,
Cinti S, Spiegelman BM. 2011. Prdm16 determines the thermogenic
program of subcutaneous white adipose tissue in mice. J Clin Invest
121: 96–105.
Semirale AA, Zhang X, Wiren KM. 2011. Body composition changes and
inhibition of fat development in vivo implicates androgen in regula-
tion of stem cell lineage allocation. J Cell Biochem 112: 1773–1786.
Sewter C, Blows F, Considine R, Vidal-Puig A, O’Rahilly S. 2002. Differ-
ential effects of adiposity on peroxisomal proliferator-activated recep-
tor g1 and g2 messenger ribonucleic acid expression in human
adipocytes. J Clin Endocrinol Metab 87: 4203–4207.
Shang CA, Waters MJ. 2003. Constitutively active signal transducer and
activator of transcription 5 can replace the requirement for growth
hormone in adipogenesis of 3T3-F442A preadipocytes. Mol Endocri-
nol 17: 2494–2508.
Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada
M, Sato K, Schiekofer S, Ohashi K, et al. 2004. Adiponectin-mediated
modulation of hypertrophic signals in the heart. Nat Med 10: 1384–
1389.
Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Gold-
stein JL. 1997a. Isoform 1c of sterol regulatory element binding protein
is less active than isoform 1a in livers of transgenic mice and in cul-
tured cells. J Clin Invest 99: 846–854.
Shimano H, Shimomura I, Hammer RE, Herz J, Goldstein JL, Brown MS,
Horton JD. 1997b. Elevated levels of SREBP-2 and cholesterol syn-
thesis in livers of mice homozygous for a targeted disruption of the
SREBP-1 gene. J Clin Invest 100: 2115–2124.
Shimizu Y, Kielar D, Minokoshi Y, Shimazu T. 1996. Noradrenaline in-
creases glucose transport into brown adipocytes in culture by a mech-
anism different from that of insulin. Biochem J 314 (Pt 2): 485–490.
Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS. 1997.
Differential expression of exons 1a and 1c in mRNAs for sterol regu-
latory element binding protein-1 in human and mouse organs and
cultured cells. J Clin Invest 99: 838–845.
Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y,
Goldstein JL, Brown MS. 1998. Insulin resistance and diabetes mellitus
in transgenic mice expressing nuclear SREBP-1c in adipose tissue:
Model for congenital generalized lipodystrophy. Genes Dev 12: 3182–
3194.
Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF,
Bhasin S. 2006. Testosterone inhibits adipogenic differentiation in
3T3-L1 cells: Nuclear translocation of androgen receptor complex
withb-catenin and T-cell factor 4 may bypass canonical Wnt signaling
to down-regulate adipogenic transcription factors. Endocrinology 147:
141–154.
Smas CM, Sul HS. 1993. Pref-1, a protein containing EGF-like repeats,
inhibits adipocyte differentiation. Cell 73: 725–734.
Smas CM, Chen L, Sul HS. 1997. Cleavage of membrane-associated pref-
1 generates a soluble inhibitor of adipocyte differentiation. Mol Cell
Biol 17: 977–988.
Smas CM, Kachinskas D, Liu CM, Xie X, Dircks LK, Sul HS. 1998.
Transcriptional control of the pref-1 gene in 3T3-L1 adipocyte differ-
entiation. Sequence requirement for differentiation-dependent sup-
pression. J Biol Chem 273: 31751–31758.
Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS. 1988. Insulin-like
growth factor-I is an essential regulator of the differentiation of 3T3-L1
adipocytes. J Biol Chem 263: 9402–9408.
Song HY, Jeon ES, Kim JI, Jung JS, Kim JH. 2007. Oncostatin M promotes
osteogenesis and suppresses adipogenic differentiation of human ad-
ipose tissue-derived mesenchymal stem cells. J Cell Biochem 101:
1238–1251.
Sopasakis VR, Sandqvist M, Gustafson B, Hammarstedt A, Schmelz M,
Yang X, Jansson PA, Smith U. 2004. High local concentrations and
effects on differentiation implicate interleukin-6 as a paracrine regu-
lator. Obes Res 12: 454–460.
Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM. 2001. Dis-
tinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol
Chem 276: 34167–34174.
Spiegelman BM, Ginty CA. 1983. Fibronectin modulation of cell shape
and lipogenic gene expression in 3T3-adipocytes. Cell 35: 657–666.
Stephens JM, Butts MD, Pekala PH. 1992. Regulation of transcription
factor mRNA accumulation during 3T3-L1 preadipocyte differentia-
tion by tumour necrosis factor-a. J Mol Endocrinol 9: 61–72.
Stephens JM, Morrison RF, Pilch PF. 1996. The expression and regulation
of STATs during 3T3-L1 adipocyte differentiation. J Biol Chem 271:
10441–10444.
Stephens JM, Lumpkin SJ, Fishman JB. 1998. Activation of signal trans-
ducers and activators of transcription 1 and 3 by leukemia inhibitory
factor, oncostatin-M, and interferon-g in adipocytes. J Biol Chem 273:
31408–31416.
Stephens JM, Morrison RF, Wu Z, Farmer SR. 1999. PPARg ligand-de-
pendent induction of STAT1, STAT5A, and STAT5B during adipogen-
esis. Biochem Biophys Res Commun 262: 216–222.
Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel
HR, Ahima RS, Lazar MA. 2001. The hormone resistin links obesity to
diabetes. Nature 409: 307–312.
Stewart WC, Morrison RF, Young SL, Stephens JM. 1999. Regulation of
signal transducers and activators of transcription (STATs) by effectors
of adipogenesis: Coordinate regulation of STATs 1, 5A, and 5B with
peroxisome proliferator-activated receptor-g and C/AAAT enhancer
binding protein-a. Biochim Biophys Acta 1452: 188–196.
Stewart WC, Pearcy LA, Floyd ZE, Stephens JM. 2011. STAT5A expression
in Swiss 3T3 cells promotes adipogenesis in vivo in an athymic mice
model system. Obesity (Silver Spring) 19: 1731–1734.
Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS.
2010. T-cell recruitment and Th1 polarization in adipose tissue during
diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring) 18:
1918–1925.
Sul HS. 2009. Minireview: Pref-1: Role in adipogenesis and mesenchymal
cell fate. Mol Endocrinol 23: 1717–1725.
Tanaka T, Yoshida N, Kishimoto T, Akira S. 1997. Defective adipocyte
differentiation in mice lacking the C/EBPb and/or C/EBPd gene.
EMBO J 16: 7432–7443.
Tang QQ, Otto TC, Lane MD. 2004. Commitment of C3H10T1/2 plu-
ripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci 101:
9607–9611.
Taylor SM, Jones PA. 1979. Multiple new phenotypes induced in 10T1/2
and 3T3 cells treated with 5-azacytidine. Cell 17: 771–779.
Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D,
Brown M, Bodner S, Grosveld G, Ihle JN. 1998. Stat5a and Stat5b
proteins have essential and nonessential, or redundant, roles in cyto-
kine responses. Cell 93: 841–850.
Tenney R, Stansfield K, Pekala PH. 2005. Interleukin 11 signaling in 3T3-
L1 adipocytes. J Cell Physiol 202: 160–166.
Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS. 2000.
Function of GATA transcription factors in preadipocyte–adipocyte
transition. Science 290: 134–138.
Tong Q, Tsai J, Tan G, Dalgin G, Hotamisligil GS. 2005. Interaction
between GATA and the C/EBP family of transcription factors is critical
in GATA-mediated suppression of adipocyte differentiation. Mol Cell
Biol 25: 706–715.
Tontonoz P, Kim JB, Graves RA, Spiegelman BM. 1993. ADD1: A novel
helix-loop-helix transcription factor associated with adipocyte deter-
mination and differentiation. Mol Cell Biol 13: 4753–4759.
Tontonoz P, Hu E, Spiegelman BM. 1994. Stimulation of adipogenesis in
fibroblasts by PPARg2, a lipid-activated transcription factor. Cell 79:
1147–1156.
Torti FM, Dieckmann B, Beutler B, Cerami A, Ringold GM. 1985. A
macrophage factor inhibits adipocyte gene expression: An in vitro
model of cachexia. Science 229: 867–869.
K. Sarjeant and J.M. Stephens
18 Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008417
Harbor Laboratory Press 
 at LOUISIANA STATE UNIV on September 29, 2021 - Published by Cold Springhttp://cshperspectives.cshlp.org/Downloaded from 
Vegiopoulos A, Herzig S. 2007. Glucocorticoids, metabolism and meta-
bolic diseases. Mol Cell Endocrinol 275: 43–61.
Vinson CR, Sigler PB, McKnight SL. 1989. Scissors-grip model for DNA
recognition by a family of leucine zipper proteins. Science 246: 911–
916.
Wabitsch M, Braun S, Hauner H, Heinze E, Ilondo MM, Shymko R, De
Meyts P, Teller WM. 1996a. Mitogenic and antiadipogenic properties
of human growth hormone in differentiating human adipocyte pre-
cursor cells in primary culture. Pediatr Res 40: 450–456.
Wabitsch M, Heinze E, Hauner H, Shymko RM, Teller WM, De Meyts P,
Ilondo MM. 1996b. Biological effects of human growth hormone in
rat adipocyte precursor cells and newly differentiated adipocytes in
primary culture. Metabolism 45: 34–42.
Wade GN, Gray JM, Bartness TJ. 1985. Gonadal influences on adiposity.
Int J Obes 9 (Suppl 1): 83–92.
Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD,
Taylor LR, Wilson DR, Darlington GJ. 1995. Impaired energy homeo-
stasis in C/EBP a knockout mice. Science 269: 1108–1112.
Wang D, Zhou Y, Lei W, Zhang K, Shi J, Hu Y, Shu G, Song J. 2010. Signal
transducer and activator of transcription 3 (STAT3) regulates adipo-
cyte differentiation via peroxisome-proliferator-activated receptor g
(PPARg). Biol Cell 102: 1–12.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante
AW Jr. 2003. Obesity is associated with macrophage accumulation in
adipose tissue. J Clin Invest 112: 1796–1808.
Weiss MJ, Orkin SH. 1995. GATA transcription factors: Key regulators of
hematopoiesis. Exp Hematol 23: 99–107.
White UA, Stewart WC, Mynatt RL, Stephens JM. 2008. Neuropoietin
attenuates adipogenesis and induces insulin resistance in adipocytes. J
Biol Chem 283: 22505–22512.
Wu Z, Bucher NL, Farmer SR. 1996. Induction of peroxisome prolifer-
ator-activated receptor g during the conversion of 3T3 fibroblasts into
adipocytes is mediated by C/EBPb, C/EBPd, and glucocorticoids.
Mol Cell Biol 16: 4128–4136.
Wu J, Srinivasan SV, Neumann JC, Lingrel JB. 2005. The KLF2 transcrip-
tion factor does not affect the formation of preadipocytes but inhibits
their differentiation into adipocytes. Biochemistry 44: 11098–11105.
Xu XF, Bjorntorp P. 1987. Effects of sex steroid hormones on differenti-
ation of adipose precursor cells in primary culture. Exp Cell Res 173:
311–321.
Xue B, Coulter A, Rim JS, Koza RA, Kozak LP. 2005. Transcriptional
synergy and the regulation of Ucp1 during brown adipocyte induction
in white fat depots. Mol Cell Biol 25: 8311–8322.
Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T,
Tomita S, Okazaki H, Tamura Y, Iizuka Y, et al. 2002. Absence of sterol
regulatory element-binding protein-1 (SREBP-1) ameliorates fatty
livers but not obesity or insulin resistance in Lepob/Lepob mice. J
Biol Chem 277: 19353–19357.
Yamashita D, Yamaguchi T, Shimizu M, Nakata N, Hirose F, Osumi T.
2004. The transactivating function of peroxisome proliferator-activat-
ed receptor g is negatively regulated by SUMO conjugation in the
amino-terminal domain. Genes Cells 9: 1017–1029.
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S,
Noda M, Kita S, Ueki K, et al. 2002. Adiponectin stimulates glucose
utilization and fatty-acid oxidation by activating AMP-activated pro-
tein kinase. Nat Med 8: 1288–1295.
Yang H, Youm YH, Vandanmagsar B, Ravussin A, Gimble JM, Greenway
F, Stephens JM, Mynatt RL, Dixit VD. 2010. Obesity increases the
production of proinflammatory mediators from adipose tissue T cells
and compromises TCR repertoire diversity: Implications for systemic
inflammation and insulin resistance. J Immunol 185: 1836–1845.
Yarwood SJ, Sale EM, Sale GJ, Houslay MD, Kilgour E, Anderson NG.
1999. Growth hormone-dependent differentiation of 3T3-F442A pre-
adipocytes requires Janus kinase/signal transducer and activator of
transcription but not mitogen-activated protein kinase or p70 S6 ki-
nase signaling. J Biol Chem 274: 8662–8668.
Yeh WC, Cao Z, Classon M, McKnight SL. 1995. Cascade regulation of
terminal adipocyte differentiation by three members of the C/EBP
family of leucine zipper proteins. Genes Dev 9: 168–181.
Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL,
Brown MS. 1993. SREBP-1, a basic-helix-loop-helix-leucine zipper
protein that controls transcription of the low density lipoprotein re-
ceptor gene. Cell 75: 187–197.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994.
Positional cloning of the mouse obese gene and its human homologue.
Nature 372: 425–432.
Zhang K, Guo W, Yang Y, Wu J. 2011. JAK2/STAT3 pathway is involved in
the early stage of adipogenesis through regulating C/EBPb transcrip-
tion. J Cell Biochem 112: 488–497.
Zingaretti MC, Crosta F, Vitali A, Guerrieri M, Frontini A, Cannon B,
Nedergaard J, Cinti S. 2009. The presence of UCP1 demonstrates that
metabolically active adipose tissue in the neck of adult humans truly
represents brown adipose tissue. FASEB J 23: 3113–3120.
Zvonic S, Cornelius P, Stewart WC, Mynatt RL, Stephens JM. 2003. The
regulation and activation of ciliary neurotrophic factor signaling pro-
teins in adipocytes. J Biol Chem 278: 2228–2235.
Zvonic S, Hogan JC, Arbour-Reily P, Mynatt RL, Stephens JM. 2004.
Effects of cardiotrophin on adipocytes. J Biol Chem 279: 47572–
47579.
Adipogenesis
Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008417 19
Harbor Laboratory Press 
 at LOUISIANA STATE UNIV on September 29, 2021 - Published by Cold Springhttp://cshperspectives.cshlp.org/Downloaded from 
2012; doi: 10.1101/cshperspect.a008417Cold Spring Harb Perspect Biol 
 
Kelesha Sarjeant and Jacqueline M. Stephens
 
Adipogenesis
Subject Collection  Mammalian Development
Mouse Embryo
The Dynamics of Morphogenesis in the Early
Hadjantonakis
Jaime A. Rivera-Pérez and Anna-Katerina Development
Neural Progenitors during Mammalian Cortical 
Cell Division Modes and Cleavage Planes of
Fumio Matsuzaki and Atsunori Shitamukai
microRNAs as Developmental Regulators
Kathryn N. Ivey and Deepak Srivastava
Blood and Lymphatic Vessel Formation
Victoria L. Bautch and Kathleen M. Caron
Development of the Endochondral Skeleton
Fanxin Long and David M. Ornitz Development
Transcriptional Networks in Liver and Intestinal
Karyn L. Sheaffer and Klaus H. Kaestner
Adipogenesis
Kelesha Sarjeant and Jacqueline M. Stephens
Pluripotency in the Embryo and in Culture
Jennifer Nichols and Austin Smith
Molecular Mechanisms of Inner Ear Development
Doris K. Wu and Matthew W. Kelley Development and Regeneration
Signaling and Transcriptional Networks in Heart
Benoit G. Bruneau
Polarity in Mammalian Epithelial Morphogenesis
Julie Roignot, Xiao Peng and Keith Mostov Cell Differentiation
Signals and Switches in Mammalian Neural Crest
Shachi Bhatt, Raul Diaz and Paul A. Trainor
Eye Development and Retinogenesis
Whitney Heavner and Larysa Pevny
Hematopoiesis
Michael A. Rieger and Timm Schroeder
Primordial Germ Cells in Mice
Mitinori Saitou and Masashi Yamaji
Embryonic Axes
Establishing Blastocyst Cell Lineages and 
Intercellular Interactions, Position, and Polarity in
P.L. Tam
Robert O. Stephenson, Janet Rossant and Patrick
http://cshperspectives.cshlp.org/cgi/collection/ For additional articles in this collection, see 
Copyright © 2012 Cold Spring Harbor Laboratory Press; all rights reserved
Harbor Laboratory Press 
 at LOUISIANA STATE UNIV on September 29, 2021 - Published by Cold Springhttp://cshperspectives.cshlp.org/Downloaded from 
